Document:

Exhibit 10.1

 

Execution Version

 

STOCK PURCHASE
AGREEMENT

 

By and Between

 

SPRINGWORKS THERAPEUTICS,
INC.

 

AND

 

Glaxo
Group Limited

 

Dated as of September
6, 2022

 

     

     

    

 

TABLE OF CONTENTS

Page

 

	1.	Definitions	1
	 	1.1	Defined Terms	1
	 	1.2	Additional Defined Terms	3
	2.	Purchase and
    Sale of Common Stock	4
	3.	Closing Date;
    Deliveries	4
	 	3.1	Closing Date	4
	 	3.2	Deliveries	4
	4.	Representations
    and Warranties of the Company	5
	 	4.1	Organization, Good Standing
    and Qualification	5
	 	4.2	Capitalization and Voting
    Rights	5
	 	4.3	Subsidiaries	6
	 	4.4	Authorization	6
	 	4.5	No Defaults	6
	 	4.6	No Conflicts	6
	 	4.7	No Governmental Authority
    or Third Party Consents	7
	 	4.8	Valid Issuance of Shares	7
	 	4.9	Litigation	7
	 	4.10	Company SEC Documents;
    Financial Statements; Nasdaq Stock Market	7
	 	4.11	Absence of Certain Changes	8
	 	4.12	OFAC
    / FCPA	8
	 	4.13	Offering	8
	 	4.14	No Integration	8
	 	4.15	Brokers’ or Finders’
    Fees	8
	5.	Representations
    and Warranties of the Purchaser	9
	 	5.1	Organization; Good Standing	9
	 	5.2	Authorization	9
	 	5.3	No Conflicts	9
	 	5.4	No Governmental Authority
    or Third Party Consents	9
	 	5.5	Purchase Entirely for
    Own Account	9
	 	5.6	Disclosure of Information	9
	 	5.7	Investment Experience
    and Accredited Purchaser Status	10
	 	5.8	Acquiring Person	10
	 	5.9	Restricted Securities	10
	 	5.10	Legends	10
	 	5.11	Financial Assurances	10
	6.	Purchaser’s
    Conditions to Closing	10
	 	6.1	Representations and Warranties	10
	 	6.2	Covenants	11
	 	6.3	No Material Adverse Effect	11
	 	6.4	Listing	11

 

    i

     

    

 

	7.	Company’s
    Conditions to Closing	11
	 	7.1	Representations
    and Warranties	11
	 	7.2	Covenants	11
	8.	Mutual Conditions
    to Closing	11
	 	8.1	Absence of Litigation	11
	 	8.2	No Prohibition	11
	9.	Termination	12
	 	9.1	Ability to Terminate	12
	 	9.2	Effect of Termination	12
	10.	Additional
    Covenants and Agreements	13
	 	10.1	Standstill	13
	 	10.2	Lock-Up	14
	 	10.3	Market Listing	14
	 	10.4	Assistance and Cooperation	14
	 	10.5	Effect of Waiver of Condition
    to Closing	15
	11.	Miscellaneous	15
	 	11.1	Governing Law; Submission
    to Jurisdiction	15
	 	11.2	Waiver	15
	 	11.3	Notices	15
	 	11.4	Entire Agreement	15
	 	11.5	Amendments	15
	 	11.6	Headings; Nouns and Pronouns;
    Section References	16
	 	11.7	Severability	16
	 	11.8	Assignment	16
	 	11.9	Successors and Assigns	16
	 	11.10	Counterparts	16
	 	11.11	Third Party Beneficiaries	16
	 	11.12	No Strict Construction	16
	 	11.13	Survival of Warranties	16
	 	11.14	Remedies	17
	 	11.15	Expenses	17
	 	11.16	Public Announcement	17

 

Exhibit A – Form of Cross Receipt

Exhibit B – Notices

Exhibit C – Form of Form 8-K

 

    ii

     

    

 

STOCK PURCHASE
AGREEMENT

 

THIS
STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of September 6, 2022, by and between Glaxo Group Limited
(the “Purchaser”), a company existing under the laws of England with offices located at 980 Great West Road, Brentford,
Middlesex, TW8 9GS, England, and SpringWorks Therapeutics, Inc. (the “Company”), a Delaware corporation, with its principal
place of business at 100 Washington Blvd, Stamford, Connecticut, 06902.

 

WHEREAS,
the Company and an Affiliate (defined below) of Purchaser are party to an Amended and Restated Collaboration and License Agreement of
even date herewith (the “License Agreement”).

 

WHEREAS,
in connection with the entry into the License Agreement, the Company desires to issue, and Purchaser desires to purchase, shares
of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) as
herein described, on the terms and conditions hereinafter set forth.

 

NOW,
THEREFORE, in consideration of the following mutual promises and obligations, and for good and valuable consideration, the adequacy and
sufficiency of which are hereby acknowledged, the Purchaser and the Company agree as follows:

 

1.                 
Definitions.

 

1.1             
Defined Terms. When used in this Agreement, the following terms shall have the respective
meanings specified therefor below:

 

“Acquisition
Transaction” shall mean (i) any sale, license, lease, exchange, transfer or other disposition of the assets of the Company or
any subsidiary of the Company constituting more than 50% of the consolidated assets of the Company or accounting for more than 50% of
the consolidated revenues of the Company in any one transaction or in a series of related transactions; or (ii) any merger, consolidation,
business combination, share exchange, reorganization or similar transaction or series of related transactions involving the Company or
any subsidiary of the Company whereby the holders of voting capital stock of the Company immediately prior to any such transaction hold
less than 50% of the voting capital stock of the Company or the surviving corporation (or its parent company) immediately after the consummation
of any such transaction.

 

“Affiliate”
shall mean, with respect to a Person, any other Person which controls, is controlled by or is under common control with the applicable
Person. For purposes of this definition, “control” shall mean: (a) in the case of corporate entities, direct or indirect ownership
of at least fifty percent (50%) of the stock or shares entitled to vote for the election of directors, or otherwise having the power to
control or direct the affairs of such Person; and (b) in the case of non-corporate entities, direct or indirect ownership of at least
fifty percent (50%) of the equity interest or the power to direct the management and policies of such non-corporate entities.

 

“Agreement”
shall have the meaning set forth in the Preamble, including all Exhibits attached hereto.

 

     

     

    

 

“Business
Day” shall mean a day on which the Nasdaq and commercial banking institutions in New York, New York are open for business.

 

“Cross
Receipt” shall mean an executed document signed by each of the Company and the Purchaser, in substantially the form of Exhibit
A attached hereto.

 

“Effect”
shall have the meaning set forth in the definition of “Material Adverse Effect.”

 

“Governmental
Authority” shall mean any applicable government authority, court, tribunal, arbitrator, agency, department, legislative body,
commission or other instrumentality of (a) any government of any country or territory, (b) any nation, state, province, county, city or
other political subdivision thereof or (c) any supranational body.

 

“Law”
or “Laws” shall mean all laws, statutes, rules, regulations, orders, judgments, injunctions and/or ordinances of any
Governmental Authority.

 

“Material
Adverse Effect” shall mean any change, event or occurrence (each, an “Effect”) that, individually or when taken
together with all other Effects, has (i) a material adverse effect on the business, financial condition, assets, results of operations
or prospects of the Company and its subsidiaries, taken as a whole, or (ii) a material adverse effect on the Company’s ability to
perform its obligations, or consummate the Transaction, in accordance with the terms of this Agreement, except in the case of (i) or (ii)
to the extent that any such Effect results from or arises out of: (A) changes in conditions in the United States or global economy or
capital or financial markets generally, including changes in interest or exchange rates, (B) changes in general legal, regulatory, political,
economic or business conditions or changes in generally accepted accounting principles in the United States or interpretations thereof
that, in each case, generally affect the biotechnology or biopharmaceutical industries, (C) the announcement of this Agreement or the
License Agreement, or the identity of the Purchaser, (D) any change in the trading prices or trading volume of the Common Stock (it being
understood that the facts giving rise to or contributing to any such change may be deemed to constitute, or be taken into account when
determining whether there has been or will be, a Material Adverse Effect, except to the extent any of such facts is an Effect referred
in clauses (A) through (H) of this definition), (E) acts of war, sabotage or terrorism, or any escalation or worsening of any such acts
of war, sabotage or terrorism, (F) earthquakes, hurricanes, floods or other natural disasters, (G) any action taken by the Company with
the Purchaser’s written consent, (H) any breach, violation or non-performance by the Purchaser or any of its Affiliates under the
License Agreement, or (I) shareholder litigation arising out of or in connection with the execution, delivery or performance of this Agreement
or the License Agreement; provided, that with respect to clauses (A), (B), (E) and (F) such Effect does not have a materially disproportionate
and adverse effect on the Company relative to other companies in the biotechnology or biopharmaceutical industries.

 

“Organizational
Documents” shall mean (i) the Amended and Restated Certificate of Incorporation of the Company dated as of September 17, 2019,
as amended through the date of this Agreement and (ii) the Amended and Restated Bylaws of the Company, as amended through the date of
this Agreement.

 

    2

     

    

 

“Permitted
Transferee” shall mean an Affiliate of the Purchaser; provided, however, that no such Affiliate shall be deemed a Permitted
Transferee for any purpose under this Agreement unless the Permitted Transferee, prior to or simultaneously with such transfer or assignment,
shall have agreed in writing with the Company to be subject to and bound by all restrictions and obligations applicable to such Purchaser
set forth in this Agreement. Following such transfer, the Permitted Transferee shall be deemed to be a Purchaser for all purposes under
this Agreement.

 

“Person”
shall mean any individual, partnership, limited liability company, firm, corporation, trust, unincorporated organization, government or
any department or agency thereof or other entity, as well as any syndicate or group that would be deemed to be a Person under Section
13(d)(3) of the Exchange Act.

 

“Third
Party” shall mean any Person (other than a Governmental Authority) other than the Purchaser, the Company or any Affiliate of
the Purchaser or the Company.

 

“Transaction”
means the issuance and sale of the Shares by the Company, and the purchase of the Shares by the Purchaser, in accordance with the terms
hereof.

 

“Transaction
Agreements” means this Agreement and the License Agreement.

 

1.2             
Additional Defined Terms. In addition to the terms defined in Section 1.1, the following
terms shall have the respective meanings assigned thereto in the sections indicated below:

 

	Defined Term	Section
	Aggregate Purchase Price	Section 2
	Agreed Disclosures	Section 11.17
	Agreement	Preamble
	Board	Section 3.2(a)
	Change of Control	Section 10.2
	Closing	Section 3.1
	Closing Date	Section 3.1
	Common Stock	Preamble
	Company	Preamble
	Company SEC Documents	Section 4.10(a)
	Exchange Act	Section 4.10(a)
	LAS	Section 4.7
	License Agreement	Preamble
	Lock-Up Period	Section 10.2
	Lock-Up Securities	Section 10.2
	Modified Clause	Section 11.7
	Purchaser	Preamble
	SEC	Section 4.7
	Securities Act	Section 4.10(a)
	Share Amount	Section 2
	Shares	Section 2
	Standstill Period	Section 10.1
	Standstill Restrictions	Section 10.1
	Termination Date	Section 9.1

 

    3

     

    

 

2.                 
Purchase and Sale of Common Stock. Subject to the terms and conditions of this Agreement,
at the Closing, the Company shall issue and sell to the Purchaser, free and clear of all liens, other than any liens arising as a result
of any action by the Purchaser, and the Purchaser shall purchase from the Company, a number of shares of Common Stock equal to the Share
Amount (the “Shares”), for a purchase price of $36.57 per share and an aggregate purchase price of US $74,999,988.94
(the “Aggregate Purchase Price”). The “Share Amount” shall equal 2,050,819 shares of Common Stock;
provided, however, that in the event of any stock dividend, stock split, combination of shares, recapitalization or other similar change
in the capital structure of the Company after the date hereof and on or prior to the Closing which affects or relates to the Common Stock,
the Share Amount shall be adjusted proportionately.

 

3.                 
Closing Date; Deliveries.

 

3.1             
Closing Date. Subject to the satisfaction or waiver of all the conditions to the Closing
set forth in Sections 7, 8 and 9 hereof, the closing of the purchase and sale of the Shares hereunder (the “Closing”)
shall be held on the third (3rd) Business Day after the satisfaction of the conditions to Closing set forth in Sections 7,
8 and 9 (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction at such
time of such conditions), at 10:00 a.m. New York time (ET), at the offices of Goodwin Procter LLP, 100 Northern Avenue, Boston, Massachusetts
02210, or at such other time, date and location as the parties may agree. The date the Closing occurs is hereinafter referred to as the
“Closing Date.”

 

3.2             
Deliveries.

 

(a)              
Deliveries by the Company. At the Closing, the Company shall instruct its transfer
agent to register the Shares in book-entry in the name of the Purchaser. The Company shall also deliver at the Closing: (i) a duly executed
Cross Receipt; (ii) a certificate in form and substance reasonably satisfactory to the Purchaser and duly executed on behalf of the Company
by an authorized executive officer of the Company, certifying that the conditions to Closing set forth in Section 6 of this Agreement
have been fulfilled; and (iii) a certificate of the secretary of the Company dated as of the Closing Date certifying (A) that attached
thereto is a true and complete copy of the Amended and Restated Bylaws of the Company as in effect at the time of the actions by the board
of directors of the Company (the “Board”) referred to in clause (B) below, and on the Closing Date; (B) that attached
thereto is a true and complete copy of all resolutions adopted by the Board authorizing the execution, delivery and performance of this
Agreement and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions
contemplated hereby as of the Closing Date; (C) that attached thereto is a true and complete copy of the Company’s Amended and Restated
Certificate of Incorporation as in effect at the time of the actions by the Board referred to in clause (B) above, and on the Closing
Date.

 

(b)               Deliveries
by the Purchaser. At the Closing, the Purchaser shall deliver, or cause to be delivered, to the Company the Aggregate Purchase
Price by wire transfer of immediately available United States funds to an account designated by the Company. The Company shall
notify the Purchaser in writing of the wiring instructions for such account not less than three (3) Business Days before the Closing
Date. The Purchaser shall also deliver, or cause to be delivered, at the Closing: (i) a duly executed Cross Receipt; and (ii) a
certificate in form and substance reasonably satisfactory to the Company duly executed by an authorized executive officer of the
Purchaser certifying that the conditions to Closing set forth in Section 7 of this Agreement have been fulfilled.

 

    4

     

    

 

4.                 
Representations and Warranties of the Company. The Company hereby represents and warrants
to the Purchaser that:

 

4.1             
Organization, Good Standing and Qualification.

 

(a)              
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.
The Company has all requisite corporate power and corporate authority to own, lease and operate its properties and assets, to carry on
its business as now conducted, and as proposed to be conducted as described in the Company SEC Documents, to enter into the Transaction
Agreements to issue and sell the Shares and to carry out the other transactions contemplated by the Transaction Agreements.

 

(b)              
The Company is qualified to transact business and is in good standing in each jurisdiction in which the character of the
properties owned, leased or operated by the Company or the nature of the business conducted by the Company makes such qualification necessary,
except where the failure to be so qualified would not have or be reasonably likely to have a Material Adverse Effect.

 

4.2             
Capitalization and Voting Rights.

 

(a)              
The authorized capital of the Company as of the date hereof consists of: (i) 150,000,000
shares of Common Stock of which, as of the date of this Agreement, 51,729,931 shares are issued and 51,699,732 shares are outstanding
and (ii) 10,000,000 shares of preferred stock, par value $0.0001 per share, of which no shares are issued and outstanding as of the date
of this Agreement. All of the issued and outstanding shares of Common Stock (A) have been duly authorized and validly issued and (B) are
fully paid and non-assessable. 

 

(b)              
All of the authorized shares of Common Stock are entitled to one (1) vote per share.

 

(c)              
Except as described or referred to in Section 4.2(a) above and as set forth in the
Company SEC Documents, as of the date hereof, there are not: (i) any outstanding equity securities, options, warrants, rights (including
conversion or preemptive rights) or other agreements pursuant to which the Company is or may become obligated to issue, sell or repurchase
any shares of its capital stock or any other securities of the Company or (ii) any restrictions on the transfer of capital stock of the
Company other than pursuant to state and federal securities Laws. 

 

(d)                Except
as set forth in the Company SEC Documents, the Company is not a party to or subject to any agreement or understanding relating to
the voting of shares of capital stock of the Company or the giving of written consents by a stockholder or director of the
Company.

 

    5

     

    

 

4.3             
Subsidiaries. The Company has disclosed all of its
subsidiaries required to be disclosed pursuant to Item 601(b)(21) of Regulation S-K in an exhibit to its Annual Report on Form 10-K for
the fiscal year ended December 31, 2021. 

 

4.4             
Authorization.

 

(a)              
All requisite corporate action on the part of the Company, its directors and stockholders
required by applicable Law for the authorization, execution and delivery by the Company of the Transaction Agreements, and the performance
of all obligations of the Company hereunder and thereunder, including the authorization, issuance and delivery of the Shares, has been
taken.

 

(b)              
This Agreement and the License Agreement have been duly executed and delivered by the Company, and upon the due execution
and delivery of this Agreement and the License Agreement by the Purchaser, this Agreement and the License Agreement will constitute valid
and legally binding obligations of the Company, enforceable against the Company in accordance with their respective terms (except as such
enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium or other Laws of general application
relating to or affecting enforcement of creditors’ rights and (ii) rules of Law governing specific performance, injunctive relief
or other equitable remedies and limitations of public policy).

 

4.5             
No Defaults. The Company is not in default under or in violation of (a) its Organizational
Documents, (b) any provision of applicable Law or any ruling, writ, injunction, order, Permit, judgment or decree of any Governmental
Authority or (c) any agreement, arrangement or instrument, whether written or oral, by which the Company or any of its assets are bound,
except, in the case of subsections (b) and (c), as would not have or be reasonably likely to have a Material Adverse Effect. To the knowledge
of the Company, there exists no condition, event or act which after notice, lapse of time, or both, would constitute a default or violation
by the Company under any of the foregoing, except, in the case of subsections (b) and (c), as would not have or be reasonably likely to
have a Material Adverse Effect.

 

4.6             
No Conflicts. The execution, delivery and performance of the Transaction Agreements, and
compliance with the provisions hereof and thereof, by the Company do not and shall not: (a) violate any provision of applicable Law or
any ruling, writ, injunction, order, permit, judgment or decree of any Governmental Authority, (b) constitute a breach of, or default
under (or an event which, with notice or lapse of time or both, would become a default under) or conflict with, or give rise to any right
of termination, cancellation or acceleration of, any agreement, arrangement or instrument, whether written or oral, by which the Company
or any of its assets are bound, (c) result in any encumbrance upon any of the Shares, other than restrictions on resale pursuant to securities
laws, or on any of the properties or assets of the Company or any subsidiary or (d) violate or conflict with any of the provisions of
the Company’s Organizational Documents, except, in the case of subsections (a), (b) and (c) as would not have or be reasonably likely
to have a Material Adverse Effect with respect to this Agreement. 

 

    6

     

    

 

4.7             
 No Governmental Authority or Third Party Consents. No consent, approval, authorization
or other order of, or filing with, or notice to, any Governmental Authority or other Third Party is required to be obtained or made by
the Company in connection with the authorization, execution and delivery by the Company of any of the Transaction Agreements, or with
the authorization, issue and sale by the Company of the Shares, except (i) such filings as may be required to be made with the Securities
and Exchange Commission (the “SEC”) and with any state blue sky or securities regulatory authority, which filings shall
be made in a timely manner in accordance with all applicable Laws and (ii) with respect to the Shares, the filing with The Nasdaq Stock
Market LLC of a Notification Form: Listing of Additional Shares (the “LAS”).

 

4.8             
Valid Issuance of Shares. When issued, sold and delivered at the Closing in accordance
with the terms hereof for the Aggregate Purchase Price, the Shares will be duly authorized, validly issued, fully paid and nonassessable,
free from any liens, encumbrances or restrictions on transfer, including preemptive rights, rights of first refusal or other similar rights
as a result of any action by the Purchaser or under federal or state securities Laws.

 

4.9             
Litigation. Except as set forth in the Company SEC
Documents filed prior to the date of this Agreement, there is no action, suit, proceeding or investigation pending (of which the Company
has received notice or otherwise has knowledge) or, to the Company’s knowledge, threatened, against the Company or which the Company
intends to initiate which has had or is reasonably likely to have a Material Adverse Effect.

 

4.10         
Company SEC Documents; Financial Statements; Nasdaq Stock Market.

 

(a)              
Since December 31, 2020, the Company has timely filed all required reports, schedules, forms, statements and other documents
(including exhibits and all other information incorporated therein), and any required amendments to any of the foregoing, with the SEC
(the “Company SEC Documents”). As of their respective filing dates, each of the Company SEC Documents complied in all
material respects with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder
applicable to such Company SEC Documents, and no Company SEC Documents when filed, declared effective or mailed, as applicable, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading.

 

(b)              
As of the date of this Agreement, the Common Stock is listed on The Nasdaq Global Select Market, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act or delisting the Common Stock from The Nasdaq Global Select Market. As of the date of this Agreement, the Company has
not received any notification that, and has no knowledge that, the SEC or The Nasdaq Stock Market LLC is contemplating terminating such
listing or registration.

 

(c)              
The financial statements of the Company included in its Annual Report on Form 10-K for the fiscal year ended December 31,
2021 comply as to form in all material respects with applicable accounting requirements and the published rules and regulations of the
SEC with respect thereto, have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (except as may be indicated in the notes thereto) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended. Except (i)
as set forth in the Company SEC Documents or (ii) for liabilities incurred in the ordinary course of business subsequent to the date
of the most recent balance sheet contained in the Company SEC Documents, the Company has no liabilities, whether absolute or accrued,
contingent or otherwise, other than those that would not, individually or in the aggregate, have or be reasonably likely to have a Material
Adverse Effect. There are no material unconsolidated subsidiaries of the Company or any material off-balance sheet arrangements of any
type (including any off-balance sheet arrangement required to be disclosed pursuant to Item 303(a)(4) of Regulation S-K promulgated under
the Securities Act) that have not been so described in the SEC Documents filed prior to the date hereof nor any obligations to enter
into any such arrangements.

 

    7

     

    

 

4.11         
Absence of Certain Changes. Except as disclosed
in the Company SEC Documents filed prior to the date hereof, since December 31, 2021, there has not occurred any Effect that has caused
or would reasonably be expected to cause a Material Adverse Effect.

 

4.12         
OFAC / FCPA. Neither
the Company nor, to the Company’s knowledge, any director, officer, agent, employee or Affiliate of the Company is currently subject
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department. Neither the Company, nor to
the Company’s knowledge, any director, officer, agent, employee, Affiliate or other person acting on behalf of the Company has,
in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of in any material respect
any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

 

4.13         
Offering. Subject to the accuracy of the Purchaser’s representations set forth in
Sections 5.5, 5.6, 5.7, 5.9 and 5.10, the offer, sale and issuance of the Shares to be issued in conformity with the terms of this Agreement
constitute transactions which are exempt from the registration requirements of the Securities Act and from all applicable state registration
or qualification requirements. Neither the Company nor any Person acting on its behalf will take any action that would cause the loss
of such exemption.

 

4.14         
No Integration. The Company has not, directly or through any agent, sold, offered for
sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act) which is or will
be integrated with the Shares sold pursuant to this Agreement in a manner that would require the registration of the Shares under the
Securities Act.

 

4.15         
Brokers’ or Finders’ Fees. No broker, finder, investment banker or other Person
is entitled to any brokerage, finder’s or other fee or commission from the Company in connection with the transactions contemplated
by the Transaction Agreements.

 

    8

     

    

 

5.                 
 Representations and Warranties of the Purchaser. The Purchaser hereby represents and
warrants to the Company, that:

 

5.1             
Organization; Good Standing. The Purchaser is a company duly organized, validly existing
and in good standing under the laws of England. The Purchaser has or will have all requisite power and authority to enter into this Agreement,
to purchase the Shares and to perform its obligations under and to carry out the other transactions contemplated by this Agreement.

 

5.2             
Authorization. All requisite action on the part of the Purchaser and its directors and
stockholders, required by applicable Law for the authorization, execution and delivery by the Purchaser of this Agreement, and the performance
of all of its obligations thereunder, including the subscription for and purchase of the Shares, has been taken. This Agreement has been
duly executed and delivered by the Purchaser and upon the due execution and delivery thereof by the Company, will constitute a valid and
legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms (except as such enforceability
may be limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium or other Laws of general application relating to or
affecting enforcement of creditors’ rights and (ii) rules of Law governing specific performance, injunctive relief or other equitable
remedies and limitations of public policy).

 

5.3             
No Conflicts. The execution, delivery and performance of this Agreement, and compliance
with the provisions thereof, by the Purchaser do not and shall not: (a) violate any provision of applicable Law or any ruling, writ, injunction,
order, permit, judgment or decree of any Governmental Authority, (b) constitute a breach of, or default under (or an event which, with
notice or lapse of time or both, would become a default under) or conflict with, or give rise to any right of termination, cancellation
or acceleration of, any agreement, arrangement or instrument, whether written or oral, by which the Purchaser or any of its assets, are
bound, or (c) violate or conflict with any of the provisions of the Purchaser’s organizational documents (including any articles
or memoranda of organization or association, charter, bylaws or similar documents), except as would not impair or adversely affect the
ability of the Purchaser to consummate the Transaction and perform its obligations under this Agreement.

 

5.4             
No Governmental Authority or Third Party Consents. No consent, approval, authorization
or other order of any Governmental Authority or other Third Party is required to be obtained by the Purchaser in connection with the authorization,
execution and delivery of this Agreement, or with the subscription for and purchase of the Shares.

 

5.5             
Purchase Entirely for Own Account. The Shares shall be acquired for investment for the
Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the
Purchaser has no present intention of selling, granting any participation or otherwise distributing the Shares. The Purchaser does not
have and will not have as of the Closing any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant
participation to a Person any of the Shares.

 

5.6              Disclosure
of Information. The Purchaser has received all the information from the Company and its management
that the Purchaser considers necessary or appropriate for deciding whether to purchase the Shares hereunder. The Purchaser further
represents that it has had an opportunity to ask questions and receive answers from the Company regarding the Company, its financial
condition, results of operations and prospects and the terms and conditions of the offering of the Shares sufficient to enable it to
evaluate its investment.

 

    9

     

    

 

5.7             
Investment Experience and Accredited Purchaser Status. The Purchaser is an “accredited
investor” (as defined in Regulation D under the Securities Act). The Purchaser has such knowledge and experience in financial or
business matters that it is capable of evaluating the merits and risks of the investment in the Shares to be purchased hereunder.

 

5.8             
Acquiring Person. As of the date of this Agreement and immediately prior to the Closing,
neither the Purchaser nor any of its Affiliates beneficially owns, or will beneficially own (as determined pursuant to Rule 13d-3 under
the Exchange Act without regard for the number of days in which a Person has the right to acquire such beneficial ownership, and without
regard to Purchaser’s rights under this Agreement), any securities of the Company, except for securities that were purchased directly
from the Company or that may be owned by employee benefit plans of the Purchaser or its Affiliates in the ordinary course of business.

 

5.9             
Restricted Securities. The Purchaser understands that the Shares, when issued, will be
“restricted securities” under the federal securities Laws inasmuch as they are being acquired from the Company in a transaction
not involving a public offering and that under such Laws the Shares may be resold without registration under the Securities Act only in
certain limited circumstances. The Purchaser represents that it is familiar with Rule 144 of the Securities Act, as presently in effect.

 

5.10         
Legends. The Purchaser understands that any certificates or book-entries representing
the Shares shall bear the following legends:

 

“These
securities have not been registered under the Securities Act of 1933. They may not be sold, offered for sale, pledged or hypothecated
in the absence of a registration statement in effect with respect to the securities under the Securities Act or an opinion of counsel
(which counsel shall be reasonably satisfactory to SpringWorks Therapeutics, Inc.) that such registration is not required or unless sold
pursuant to Rule 144 of the Securities Act.”; and any legend required by applicable state securities Laws.

 

5.11         
Financial Assurances. As of the date hereof and as of the Closing Date, the Purchaser
has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.

 

6.                 
Purchaser’s Conditions to Closing. The Purchaser’s obligation to purchase
the Shares at the Closing is subject to the fulfillment as of such Closing of the following conditions (unless waived in writing by the
Purchaser):

 

6.1              Representations
and Warranties. The representations and warranties made by the Company in Section 4 hereof shall be
true and correct as of the date of this Agreement and as of the Closing Date as though made on and as of such Closing Date, except
to the extent such representations and warranties are specifically made as of a particular date, in which case such representations
and warranties shall be true and correct as of such date; provided, however, that for purposes of this Section 6.1,
all such representations and warranties of the Company (other than Sections 4.1(a), 4.2, 4.3, 4.4, 4.5(a), 4.6(d), 4.8, 4.10 of this
Agreement) shall be deemed to be true and correct for purposes of this Section 6.1 unless the failure or failures of such
representations and warranties to be so true and correct, without regard to any “material,” “materiality” or
“Material Adverse Effect” qualifiers set forth therein, individually or in the aggregate, has had or would reasonably be
expected to have a Material Adverse Effect.

 

    10

     

    

 

6.2             
Covenants. All covenants and agreements contained in this Agreement to be performed or
complied with by the Company on or prior to the Closing Date shall have been performed or complied with in all material respects.

 

6.3             
No Material Adverse Effect. From and after the date of this Agreement until the Closing
Date, there shall have occurred no event that has caused or would reasonably be expected to cause a Material Adverse Effect.

 

6.4             
Listing. The Shares shall be eligible for listing on the Nasdaq Global Select Market.

 

7.                 
Company’s Conditions to Closing. The Company’s obligation to issue and sell
the Shares at the Closing is subject to the fulfillment as of such Closing of the following conditions (unless waived in writing by the
Company):

 

7.1             
Representations and Warranties. The representations and warranties made by the Purchaser
in Section 5 hereof shall be true and correct as of the date of this Agreement and as of the Closing Date as though made on and as of
such Closing Date, except to the extent such representations and warranties are specifically made as of a particular date, in which case
such representations and warranties shall be true and correct as of such date.

 

7.2             
Covenants. All covenants and agreements contained in this Agreement to be performed or
complied with by the Purchaser on or prior to the Closing Date shall have been performed or complied with in all material respects.

 

8.                 
Mutual Conditions to Closing. The obligations of the Purchaser and the Company to consummate
the Closing are subject to the fulfillment as of the Closing Date of the following conditions:

 

8.1             
Absence of Litigation. There shall be no action, suit, proceeding or investigation by
a Governmental Authority pending or currently threatened in writing against the Company or the Purchaser that questions the validity of
any of the Transaction Agreements, the right of the Company or the Purchaser to enter into any Transaction Agreement or to consummate
the transactions contemplated hereby or thereby or which, if determined adversely, would impose substantial monetary damages on the Company
or the Purchaser as a result of the consummation of the transactions contemplated by any Transaction Agreement.

 

8.2              No
Prohibition. (a) No provision of any applicable Law and no judgment, injunction (preliminary or
permanent), order or decree that prohibits, makes illegal or enjoins the consummation of the Transaction shall be in effect; and (b)
the Common Stock shall be eligible for listing on the Nasdaq Global Select Market.

 

    11

     

    

 

9.                 
Termination.

 

9.1             
Ability to Terminate. This Agreement may be terminated at any time (the effective date
of such termination, the “Termination Date”) prior to the Closing by:

 

(a)              
mutual written consent of the Company and the Purchaser;

 

(b)              
either the Company or the Purchaser, upon written notice to the other, if any of the mutual conditions to the Closing set
forth in Section 8 shall have become incapable of fulfillment by the Termination Date and shall not have been waived in writing by the
other party; provided, however, that the right to terminate this Agreement under this Section 9.1(b) shall not be available
to any party whose failure to fulfill any obligation under this Agreement has been the cause of, or resulted in, the failure to consummate
the transactions contemplated hereby prior to the Termination Date;

 

(c)              
the Company, upon written notice to the Purchaser, so long as the Company is not then in breach of its representations,
warranties, covenants or agreements under this Agreement such that any of the conditions set forth in Section 7.1 or 7.2, as applicable,
could not be satisfied by the Termination Date, (i) upon a breach of any covenant or agreement on the part of the Purchaser set forth
in this Agreement, or (ii) if any representation or warranty of the Purchaser shall have been or become untrue, in each case such that
any of the conditions set forth in Section 7.1 or 7.2, as applicable, could not be satisfied by the Termination Date;

 

(d)              
the Purchaser, upon written notice to the Company, so long as the Purchaser is not then in breach of its representations,
warranties, covenants or agreements under this Agreement such that any of the conditions set forth in Section 6.1 or 6.2, as applicable,
could not be satisfied by the Termination Date, (i) upon a breach of any covenant or agreement on the part of the Company set forth in
this Agreement, or (ii) if any representation or warranty of the Company shall have been or become untrue, in each case such that any
of the conditions set forth in Section 6.1 or 6.2, as applicable, could not be satisfied by the Termination Date.

 

9.2             
Effect of Termination. In the event of the termination of this Agreement pursuant to Section
9.1 hereof, (a) this Agreement (except for this Section 9.2 and Section 11 hereof (other than Section 11.13), and any definitions set
forth in this Agreement and used in such sections) shall forthwith become void and have no effect, without any liability on the part of
any party hereto or its Affiliates, and (b) all filings, applications and other submissions made pursuant to this Agreement, to the extent
practicable, shall be withdrawn from the agency or other Person to which they were made or appropriately amended to reflect the termination
of the transactions contemplated hereby; provided, however, that nothing contained in this Section 9.2 shall relieve any
party from liability for fraud or any intentional or willful breach of this Agreement.

 

    12

     

    

 

10.             
Additional Covenants and Agreements.

 

10.1          Standstill. (a) Purchaser
hereby acknowledges that, unless otherwise agreed in writing by the Company, for a period of twelve (12) months from the date hereof
(the “Standstill Period”), neither the Purchaser nor any of its Affiliates who are provided with Confidential
Information (as defined in that Mutual Confidential Disclosure Agreement by and between the parties effective as of June 24, 2021),
will, directly or indirectly, (i) propose any merger, consolidation, business combination, tender or exchange offer, purchase of the
Company’ assets or businesses, or similar transactions involving the Company, or any recapitalization, restructuring,
liquidation or other extraordinary transaction with respect to the Company; (ii) propose or seek, whether alone or in concert with
others, any “solicitation” (as such term is used in the rules of the SEC) of proxies or consents to vote any securities
(including a Derivative) of the Company; (iii) nominate any person as a director of the Company; (iv) propose any matter to be voted
upon by the stockholders of the Company; (v) acquire or propose or seek to acquire beneficial ownership of any securities (including
in derivative form) of the Company; (vi) directly or indirectly, form, join or in any way participate in a third party
“group” (as such term is used in the rules of the SEC) (or discuss with any Third Party the potential formation of a
group) with respect to any securities (including in derivative form) of the Company; or (vii) request that the Company (or any of
its officers, directors or representatives), directly or through any representative, to amend or waive any provision of this Section
10.1 (including this sentence) (the restrictions set forth in foregoing clauses (i) through (vii), the “Standstill
Restrictions”); provided, however, that, notwithstanding anything to the contrary in this Section, prior to the expiration
or termination of the Standstill Period, Purchaser and its affiliates (x) may request (but only privately to the Board or the Chief
Executive Officer of the Company and not publicly or otherwise in a manner that could reasonably be expected to require public
disclosure of such request by either the Company or Purchaser) an amendment or waiver of, consent under or agreement not to enforce,
the Standstill Restrictions and (y) may make confidential proposals or offers to the Company or the Board with respect to a
potential transaction between the Company and Purchaser provided that such proposals or offers are not made in a manner that could
reasonably be expected to require public disclosure of such request by either the Company or Purchaser; provided, further, that the
restrictions set forth in this Section shall terminate (A) immediately upon the public announcement by the Company that it has
entered into a definitive agreement with a Third Party for a transaction involving the acquisition (by way of merger, tender offer
or otherwise) of more than 50% of the outstanding capital stock of the Company or 50% or more of the assets (on a consolidated
basis) of the Company or (B) if any Third Party commences a tender or exchange offer that, if consummated, would result in 50% or
more of the outstanding capital stock of the Company being owned by such person or group and the Board accepts (or recommends that
its stockholders accept) such offer or fails to recommend within ten (10) Business Days from the date of commencement of such offer
that its stockholders reject such offer.

 

(b)              
Notwithstanding anything to the contrary herein, the restrictions set forth in this Section shall not apply to (i) any passive
investment in any securities of the Company by or behalf of any pension, employee benefit plan or trust of Purchaser or any of its Affiliates,
including without limitation any investment in any diversified index, mutual or pension fund managed by an independent advisor, which
fund in-turn holds, directly or indirectly, securities of the Company, or (ii) securities of the Company held, directly or indirectly,
by a person acquired by Purchaser or any of its Affiliates after the date hereof; provided that in each case with respect to the foregoing
clauses (i) and (ii) such investment or acquisition was not designed to circumvent the Standstill Restrictions.

 

    13

     

    

 

10.2         
 Lock-Up. During the period commencing on the Closing Date and ending on the twelve (12)
month anniversary of the Closing Date (the “Lock-Up Period”), without the prior approval of the Board of Directors
of the Company, the Purchaser shall not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant for the sale of, or otherwise dispose of or transfer any of the Shares
(together with (a) any shares of Common Stock issued in respect thereof as a result of any stock split, stock dividend, share exchange,
merger, consolidation or similar recapitalization and (b) any shares of Common Stock issued as (or issuable upon the exercise of any warrant,
right or other security that is issued as) a dividend or other distribution with respect to, or in exchange or in replacement of, the
Shares) (the “Lock-Up Securities”), including, without limitation, any “short sale” or similar arrangement,
or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the
economic consequence of ownership of the Shares, whether any such swap or transaction is to be settled by delivery of securities, in cash
or otherwise; provided, however, that the foregoing shall not prohibit the Purchaser or its Affiliates from transferring Lock-Up Securities
to an Affiliate of the Purchaser if such transferee Affiliate executes an agreement with the Company to be bound by the restrictions set
forth in Sections 10.1 and 10.2. Notwithstanding any other provision herein, this Section 10.2 shall not prohibit or restrict any disposition
of Lock-Up Securities by the Purchaser in connection with (1) a bona fide tender offer by a Person other than the Purchaser involving
a Change of Control of the Company (as defined below), which has not been rejected by the Company’s Board of Directors, (2) an issuer
tender offer by the Company, or (3) the Company’s public announcement of a definitive agreement to consummate an Acquisition Transaction.
For the purposes of this Agreement, a “Change of Control” means the transfer, in one transaction or a series of related
transactions, as a result of which any Person or group of Persons, other than the Company, becomes the beneficial owner (as defined in
Rules 13d-3 and 13d-5 of the Exchange Act) of more than 50% of total voting power of the voting securities of the Company.

 

10.3         
Market Listing. From the date hereof through the Closing Date, Company shall use all reasonable
efforts to (a) maintain the listing and trading of the Common Stock on The Nasdaq Global Select Market and (b) effect the listing of the
Shares on The Nasdaq Global Select Market, including submitting the LAS to The Nasdaq Stock Market LLC prior to the Closing Date.

 

10.4          Assistance
and Cooperation. Prior to the Closing, upon the terms and subject to the conditions set forth in this
Agreement, each of the parties agrees to use all reasonable efforts to take, or cause to be taken, all actions and to do, or cause
to be done, and to assist and cooperate with the other party in doing, all things necessary, proper or advisable to consummate and
make effective, in the most expeditious manner practicable, the transactions contemplated by this Agreement, including using all
reasonable efforts to accomplish the following: (a) taking all reasonable acts necessary to cause the conditions precedent set forth
in Sections 6, 7 and 8 to be satisfied (including, in the case of the Company, promptly notifying the Purchaser of any notice from
The Nasdaq Stock Market LLC with respect to the LAS); (b) taking all reasonable actions necessary to obtain all necessary actions or
non-actions, waivers, consents, approvals, orders and authorizations from Governmental Authorities and the making of all necessary
registrations, declarations and filings (including registrations, declarations and filings with Governmental Authorities, if any);
and (c) taking reasonable steps to obtain all necessary consents, approvals or waivers from Third Parties.

 

    14

     

    

 

10.5         
Effect of Waiver of Condition to Closing. In the event that, as of the Closing, the Purchaser
waives the condition regarding a Material Adverse Effect set forth in Section 6.3 of this Agreement, the Purchaser shall be deemed to
have waived any right of recourse against the Company for, and agreed not to sue the Company in respect of, any and all events or inaccuracies
in any representations or warranties of the Company (a) that, as of the Closing, have caused or would reasonably be expected to cause
such Material Adverse Effect and (b) of which the Purchaser had notice in writing from the Company immediately prior to the Closing.

 

11.             
Miscellaneous.

 

11.1         
Governing Law; Submission to Jurisdiction. This Agreement shall be governed by and construed
in accordance with the Laws of the State of New York, without regard to the conflict of laws principles thereof that would require the
application of the Law of any other jurisdiction. The parties irrevocably and unconditionally submit to the exclusive jurisdiction of
the United States District Court for the Southern District of New York solely and specifically for the purposes of any action or proceeding
arising out of or in connection with this Agreement.

 

11.2         
Waiver. Waiver by a party of a breach hereunder by the other party shall not be construed
as a waiver of any subsequent breach of the same or any other provision. No delay or omission by a party in exercising or availing itself
of any right, power or privilege hereunder shall preclude the later exercise of any such right, power or privilege by such party. No waiver
shall be effective unless made in writing with specific reference to the relevant provision(s) of this Agreement and signed by a duly
authorized representative of the party granting the waiver.

 

11.3         
Notices. All notices, instructions and other communications hereunder or in connection
herewith shall be in writing, shall be sent to the address of the relevant party set forth on Exhibit B attached hereto, or at
such other address as such party may designate by ten days’ advance written notice to the other party, and shall be deemed effectively
given: (i) upon personal delivery to the party to be notified; (ii) when sent by confirmed e-mail if sent during normal business hours
of the recipient, and if not during normal business hours of the recipient, then on the next Business Day; (iii) five calendar days after
having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one Business Day after deposit with
a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. Either party may change
its address by giving notice to the other party in the manner provided above.

 

11.4         
Entire Agreement. This Agreement and the License Agreement contain the entire agreement
among the parties with respect to the subject matter hereof and thereof and supersede all prior and contemporaneous arrangements or understandings,
whether written or oral, with respect hereto and thereto.

 

11.5         
Amendments. No provision in this Agreement shall be supplemented, deleted or amended except
in a writing executed by an authorized representative of each of the Purchaser and the Company.

 

    15

     

    

 

11.6         
 Headings; Nouns and Pronouns; Section References. Headings in this Agreement are for
convenience of reference only and shall not be considered in construing this Agreement. Whenever the context may require, any pronouns
used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of names and pronouns shall include
the plural and vice-versa. References in this Agreement to a section or subsection shall be deemed to refer to a section or subsection
of this Agreement unless otherwise expressly stated.

 

11.7         
Severability. If, under applicable Laws, any provision hereof is invalid or unenforceable,
or otherwise directly or indirectly affects the validity of any other material provision(s) of this Agreement in any jurisdiction (“Modified
Clause”), then, it is mutually agreed that this Agreement shall endure and that the Modified Clause shall be enforced in such
jurisdiction to the maximum extent permitted under applicable Laws in such jurisdiction; provided that the parties shall consult and use
all reasonable efforts to agree upon, and hereby consent to, any valid and enforceable modification of this Agreement as may be necessary
to avoid any unjust enrichment of either party and to match the intent of this Agreement as closely as possible, including the economic
benefits and rights contemplated herein.

 

11.8         
Assignment. Except for an assignment by the Purchaser of this Agreement or any rights
hereunder to an Affiliate (which assignment will not relieve the Purchaser of any obligation hereunder), neither this Agreement nor any
of the rights or obligations hereunder may be assigned by either the Purchaser or the Company without (a) the prior written consent of
the Company in the case of any assignment by the Purchaser or (b) the prior written consent of the Purchaser in the case of an assignment
by the Company.

 

11.9         
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and permitted assigns.

 

11.10     
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed
an original but which together shall constitute one and the same instrument.

 

11.11     
Third Party Beneficiaries. None of the provisions of this Agreement shall be for the benefit
of or enforceable by any Third Party, including any creditor of any party hereto, except that each Affiliate of the Purchaser is an express
third party beneficiary entitled to enforce this agreement directly against the Company. No Third Party shall obtain any right under any
provision of this Agreement or shall by reason of any such provision make any claim in respect of any debt, liability or obligation (or
otherwise) against any party hereto. 

 

11.12     
No Strict Construction. This Agreement has been prepared jointly and will not be construed
against either party.

 

11.13      Survival
of Warranties. The representations and warranties of the Company and the Purchaser contained in this
Agreement shall survive the Closing for eighteen (18) months, except for (a) the representations and warranties set forth in
Sections 4.1, 4.2, 4.4, 4.5(a), 4.6(d), 4.8, 4.12, 4.13, 4.14, 5.1, 5.2, 5.3(c), 5.5, 5.7, 5.8, 5.9 and 5.10, which shall survive
forever and (b) the representation and warranty of the Purchaser in Section 5.11, which shall not survive the Closing. The parties
hereby acknowledge and agree that the rights of the parties hereunder are special, unique and of extraordinary character, and that
if any party refuses or otherwise fails to act, or to cause its Affiliates to act, in accordance with the provisions of this
Agreement, such refusal or failure would result in irreparable injury to the Company or the Purchaser as the case may be, the exact
amount of which would be difficult to ascertain or estimate and the remedies at law for which would not be reasonable or adequate
compensation. Accordingly, if any party refuses or otherwise fails to act, or to cause its Affiliates to act, in accordance with the
provisions of this Agreement, then, in addition to any other remedy which may be available to any damaged party at law or in equity,
such damaged party will be entitled to seek specific performance and injunctive relief, without posting bond or other security, and
without the necessity of proving actual or threatened damages, which remedy such damaged party will be entitled to seek in any court
of competent jurisdiction.

 

    16

     

    

 

11.14     
Remedies. The rights, powers and remedies of the parties under this Agreement are cumulative
and not exclusive of any other right, power or remedy which such parties may have under any other agreement or Law. No single or partial
assertion or exercise of any right, power or remedy of a party hereunder shall preclude any other or further assertion or exercise thereof.

 

11.15     
Expenses. Each party shall pay its own fees and expenses in connection with the preparation,
negotiation, execution and delivery of the Transaction Agreements.

 

11.16     
Public Announcement The parties agree that the initial press release by the Company, and
the SEC filing on Form 8-K by the Company, each disclosing the execution and delivery of the Transaction Agreements and the transactions
contemplated thereby, shall be in the form attached to the License Agreement and the form attached hereto as Exhibit C, respectively
(collectively, the “Agreed Disclosures”). Each of the parties agrees that, other than the Agreed Disclosures or as
permitted by the immediately succeeding sentence, and except as may be required by law, rule, regulation or the requirements of any self-regulatory
organization or stock exchange listing requirements (in which case the party required to make the filing, disclosure, communication, release
or announcement shall allow the other party reasonable time to comment thereon in advance of such statement, release, filing, disclosure,
communication or announcement and will consider in good faith any comments provided by such party), each of the parties hereto will not
make any public statement, press release or other public filing, disclosure, communication, release, or announcement with respect to this
Agreement and any of the transactions contemplated by the Transaction Agreements; provided, that nothing herein shall limit or prevent
a party from making any statements, press releases or other filings, disclosures, communications, releases or announcements to the extent
reasonably related to such party exercising or enforcing any of its rights under this Agreement.

 

(Signature Page
Follows)

 

    17

     

    

 

IN WITNESS WHEREOF,
the parties have executed and delivered this Agreement as of the date first above written.

 

	 	SPRINGWORKS THERAPEUTICS,
INC.
	 	 	 
	 	 	 
		By:	/s /Saqib Islam
	 	 	Name:	Saqib Islam
	 	 	Title:	Chief Executive Officer

 

	 	Glaxo Group Limited
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Paul Money
	 	 	Name:	Paul Money
	 	 	Title:	Authorised Signatory, representing Edinburgh Pharmaceutical Industries Limited, Corporate Director

 

Signature Page
to Stock Purchase Agreement

 

     

     

    

 

EXHIBIT A

FORM OF CROSS
RECEIPT

CROSS RECEIPT

 

SpringWorks Therapeutics,
Inc. (the “Company”) hereby acknowledges receipt from Glaxo Group Limited (the
“Purchaser”) on September 9, 2022 of US$74,999,988.94, representing the purchase price for 2,050,819 shares of Common
Stock, par value $0.0001 per share, of the Company, pursuant to that certain Stock Purchase Agreement, dated as of September 6, 2022,
by and between the Purchaser and the Company.

 

	 	SPRINGWORKS THERAPEUTICS,
INC.
	 	 	 
	 	 	 
		By:	                      
	 	 	Name:	                    
	 	 	Title:	 

 

The Purchaser hereby
acknowledges receipt from the Company on September 9, 2022 of 2,050,819 shares of Common Stock, par value $0.0001 per share, of the Company,
delivered pursuant to that certain Stock Purchase Agreement, dated as of September 6, 2022, by and between the Purchaser and the Company.

 

    A-1

     

    

 

Receipt is hereby acknowledged of

the above-mentioned Shares

 

	Glaxo
Group Limited	 
	 	 
	 	 	 
	By:	 	
		Name:	 	
		Title:	 	

 

[Signature page
to Cross Receipt]

 

    A-2

     

    

 

EXHIBIT B

NOTICES

		(a)	If to Purchaser:

 

Glaxo Group Limited

980 Great West Road

Brentford, Middlesex

TW8 9GS

England

Attention: VP & Head of
Legal Business Development & Corporate

with copies to:

 

GlaxoSmithKline

259 E Grand Ave Fifth Floor, Suite
1

S. San Francisco, CA 94080

Attn: SVP & Head R&D Business
Development

 

GlaxoSmithKline

980 Great West Road

Brentford, Middlesex TW8 9GS

United Kingdom

Attn: VP and Head of Legal Business
Development & Corporate

 

Latham & Watkins LLP

12630 High Bluff Drive

San Diego, CA 92130

Attention: Steven T. Chinowsky,
Esq. / Cheston J. Larson, Esq.

Facsimile: (858) 523-5450

 

		(b)	If to the Company:

 

SpringWorks Therapeutics,
Inc.

100 Washington Blvd, 5th
Floor

Stamford, CT 06902

Attention: Chief Operating
Officer

 

with copies to:

 

SpringWorks Therapeutics,
Inc.

100 Washington Blvd

Stamford, CT 06902

Attn: General Counsel

 

Goodwin Procter LLP

100 Northern Avenue

Boston,
MA 02210

Attention: Kingsley Taft, Esq.

Facsimile: 617-801-8857

 

    B-1

     

    

 

EXHIBIT C

FORM OF 8-K

 

    C-1Document

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN
1.PURPOSE.  The purpose of this Plan is to provide incentives to attract, retain, and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Parents, Subsidiaries, and Affiliates that exist now or in the future, by offering them an opportunity to participate in the Company’s future performance through the grant of Awards.  Capitalized terms not defined elsewhere in the text are defined in Section 28.
2.SHARES SUBJECT TO THE PLAN. 
2.1.Number of Shares Available.  Subject to Sections 2.6 and 21 and any other applicable provisions hereof, the total number of Shares reserved and available for grant and issuance pursuant to this Plan as of the date of adoption of the Plan by the Board, is Six Million Seven Hundred Thousand (6,700,000) Shares, plus (a) any reserved shares not issued or subject to outstanding grants under the Company’s 2015 Equity Incentive Plan on the Effective Date (as defined below), (b) shares that are subject to awards granted under the Company’s 2005 Stock Option/Restricted Stock Plan and the Company’s 2015 Equity Incentive Plan (collectively, the “Prior Plans”) that cease to be subject to such awards by forfeiture or otherwise after the Effective Date, (c) shares issued under the Prior Plans before or after the Effective Date pursuant to the exercise of stock options that are, after the Effective Date, forfeited, (d) shares issued under the Prior Plans that are repurchased by the Company at the original issue price, and (e) shares that are subject to stock options or other awards under the Prior Plans that are used to pay the exercise price of an option or withheld to satisfy the tax withholding obligations related to any award.  Any of the Company’s Class B common stock that become available for grant pursuant to this Section 2.1 will be issued only as Shares.
2.2.Lapsed, Returned Awards.  Shares subject to Awards, and Shares issued under the Plan under any Award, will again be available for grant and issuance in connection with subsequent Awards under this Plan to the extent such Shares:  (a) are subject to issuance upon exercise of an Option or SAR granted under this Plan but which cease to be subject to the Option or SAR for any reason other than exercise of the Option or SAR, (b) are subject to Awards granted under this Plan that are forfeited or are repurchased by the Company at the original issue price, (c) are subject to Awards granted under this Plan that otherwise terminate without such Shares being issued, or (d) are surrendered pursuant to an Exchange Program.  To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan.  Shares used to pay the exercise price of an Award or withheld to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan.  For the avoidance of doubt, Shares that otherwise become available for grant and issuance because of the provisions of this Section 2.2 will not include Shares subject to Awards that initially became available because of the substitution clause in Section 21.2 hereof.
2.3.Minimum Share Reserve.  At all times the Company will reserve and keep available a sufficient number of Shares as will be required to satisfy the requirements of all outstanding Awards granted under this Plan.
2.4.Automatic Share Reserve Increase.  The number of Shares available for grant and issuance under the Plan will be increased on February 1 of each of the first ten (10) calendar years during the term of the Plan by the lesser of (a) five (5%) of the sum of the number of shares of the Company’s Class A common stock and the Company’s Class B common stock issued and outstanding on each January 31 immediately prior to the date of increase, or (b) such number of Shares determined by the Board.   
2.5.ISO Limitation.  No more than Sixty Million (60,000,000) Shares will be issued pursuant to the exercise of ISOs.  
2.6.Adjustment of Shares.  If the number of outstanding Shares is changed by a stock dividend, extraordinary dividends or distributions (whether in cash, shares, or other property, other than a 
1
        
        

regular cash dividend), recapitalization, stock split, reverse stock split, subdivision, combination, consolidation, reclassification, spin-off, or similar change in the capital structure of the Company, without consideration, then (a) the number and class of Shares reserved for issuance and future grant under the Plan set forth in Section 2.1, including shares reserved under sub-clauses (a)-(e) of Section 2.1, (b) the Exercise Prices of and number and class of Shares subject to outstanding Options and SARs, (c) the number and class of Shares subject to other outstanding Awards, (d) the maximum number and class of Shares that may be issued as ISOs set forth in Section 2.5, and (e) the maximum number and class of Shares that may be issued to an individual or to a new Employee in any one calendar year set forth in Section 3, will be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws; provided that fractions of a Share will not be issued.  

If, by reason of an adjustment pursuant to this Section 2.6, a Participant’s Award Agreement or other agreement related to any Award, or the Shares subject to such Award, covers additional or different shares of stock or securities, then such additional or different shares, and the Award Agreement or such other agreement in respect thereof, will be subject to all of the terms, conditions, and restrictions which were applicable to the Award or the Shares subject to such Award prior to such adjustment.  
3.ELIGIBILITY.  ISOs may be granted only to Employees.  All other Awards may be granted to Employees, Consultants, Directors, and Non-Employee Directors; provided such Consultants, Directors, and Non-Employee Directors render bona fide services not in connection with the offer and sale of securities in a capital-raising transaction.
4.ADMINISTRATION.
4.1.Committee Composition; Authority.  This Plan will be administered by the Committee or by the Board acting as the Committee.  Subject to the general purposes, terms, and conditions of this Plan, and to the direction of the Board, the Committee will have full power to implement and carry out this Plan, except, however, the Board will establish the terms for the grant of an Award to Non-Employee Directors.  The Committee will have the authority to:
(a)construe and interpret this Plan, any Award Agreement, and any other agreement or document executed pursuant to this Plan; 
(b)prescribe, amend, and rescind rules and regulations relating to this Plan or any Award; 
(c)select persons to receive Awards;
(d)determine the form and terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the Exercise Price, the time or times when Awards may vest and be exercised (which may be based on performance criteria) or settled, any vesting acceleration or waiver of forfeiture restrictions, the method to satisfy tax withholding obligations or any other tax liability legally due, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Committee will determine;
(e)determine the number of Shares or other consideration subject to Awards;
(f)determine the Fair Market Value in good faith and interpret the applicable provisions of this Plan and the definition of Fair Market Value in connection with circumstances that impact the Fair Market Value, if necessary;
(g)determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other Awards under this Plan or any other incentive or compensation plan of the Company or any Parent, Subsidiary, or Affiliate;
(h)grant waivers of Plan or Award conditions;
2
        

(i)determine the vesting, exercisability, and payment of Awards;
(j)correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement; 
(k)determine whether an Award has been vested and/or earned; 
(l)determine the terms and conditions of any, and to institute any Exchange Program; 
(m)reduce, waive or modify any criteria with respect to Performance Factors;
(n)adjust Performance Factors to take into account changes in law and accounting or tax rules as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events, or circumstances to avoid windfalls or hardships; 
(o)adopt terms and conditions, rules, and/or procedures (including the adoption of any subplan under this Plan) relating to the operation and administration of the Plan to accommodate requirements of local law and procedures outside of the United States or to qualify Awards for special tax treatment under laws of jurisdictions other than the United States;
(p)exercise discretion with respect to Performance Awards; 
(q)make all other determinations necessary or advisable for the administration of this Plan; and
(r)delegate any of the foregoing to one or more executive officers pursuant to a specific delegation as permitted by applicable law.
4.2.Committee Interpretation and Discretion.  Any determination made by the Committee with respect to any Award will be made in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of the Plan or Award, at any later time, and such determination will be final and binding on the Company and all persons having an interest in any Award under the Plan.  Any dispute regarding the interpretation of the Plan or any Award Agreement will be submitted by the Participant or Company to the Committee for review.  The resolution of such a dispute by the Committee will be final and binding on the Company and the Participant.  The Committee may delegate to one or more executive officers the authority to review and resolve disputes with respect to Awards held by Participants who are not Insiders, and such resolution will be final and binding on the Company and the Participant.
4.3.Section 16 of the Exchange Act.  Awards granted to Participants who are subject to Section 16 of the Exchange Act must be approved by two or more “non-employee directors” (as defined in the regulations promulgated under Section 16 of the Exchange Act).  
4.4.Documentation.  The Award Agreement for a given Award, the Plan, and any other documents may be delivered to, and accepted by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.  
4.5.Foreign Award Recipients.  Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws and practices in other countries in which the Company, its Subsidiaries, and Affiliates operate or have Employees or other individuals eligible for Awards, the Committee, in its sole discretion, will have the power and authority to:  (a) determine which Subsidiaries and Affiliates will be covered by the Plan; (b) determine which individuals outside the United States are eligible to participate in the Plan; (c) modify the terms and conditions of any Award granted to individuals outside the United States or foreign nationals to comply with applicable foreign laws, policies, customs, and practices; (d) establish subplans and modify exercise procedures, vesting conditions, and other terms and procedures to the extent the Committee determines such actions to be necessary or advisable (and such 
3
        

subplans and/or modifications shall be attached to this Plan as appendices, if necessary); and (e) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals; provided, however, that no action taken under this Section 4.5 shall (i) increase the share limitations contained in Section 2.1 hereof, or (ii) cause a violation of the Exchange Act or any other applicable securities law, the Code, or any other applicable governing statute or law.
5.OPTIONS.  An Option is the right but not the obligation to purchase a Share, subject to certain conditions, if applicable.  The Committee may grant Options to eligible Employees, Consultants, and Directors and will determine whether such Options will be Incentive Stock Options within the meaning of the Code (“ISOs”) or Nonqualified Stock Options (“NSOs”), the number of Shares subject to the Option, the Exercise Price of the Option, the period during which the Option may vest and be exercised, and all other terms and conditions of the Option, subject to the following terms of this section. 
5.1.Option Grant.  Each Option granted under this Plan will identify the Option as an ISO or an NSO.  An Option may be, but need not be, awarded upon satisfaction of such Performance Factors during any Performance Period as are set out in advance in the Participant’s individual Award Agreement.  If the Option is being earned upon the satisfaction of Performance Factors, then the Committee will: (a) determine the nature, length, and starting date of any Performance Period for each Option; and (b) select from among the Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may participate simultaneously with respect to Options that are subject to different performance goals and other criteria.
5.2.Date of Grant.  The date of grant of an Option will be the date on which the Committee makes the determination to grant such Option, or a specified future date.  The Award Agreement and a copy of this Plan will be delivered to the Participant within a reasonable time after the granting of the Option.
5.3.Exercise Period.  Options may be vested and exercisable within the times or upon the conditions as set forth in the Award Agreement governing such Option; provided, however, that no Option will be exercisable after the expiration of ten (10) years from the date the Option is granted; and provided further that no ISO granted to a person who, at the time the ISO is granted, directly or by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent or Subsidiary (“Ten Percent Stockholder”) will be exercisable after the expiration of five (5) years from the date the ISO is granted.  The Committee also may provide for Options to become exercisable at one time or from time to time, periodically or otherwise, in such number of Shares or percentage of Shares as the Committee determines.
5.4.Exercise Price.  The Exercise Price of an Option will be determined by the Committee when the Option is granted; provided that: (a) the Exercise Price of an Option will be not less than one hundred percent (100%) of the Fair Market Value of the Shares on the date of grant, and (b) the Exercise Price of any ISO granted to a Ten Percent Stockholder will not be less than one hundred ten percent (110%) of the Fair Market Value of the Shares on the date of grant.  Payment for the Shares purchased may be made in accordance with Section 11 and the Award Agreement and in accordance with any procedures established by the Company.  
5.5.Method of Exercise.  Any Option granted hereunder will be vested and exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Committee and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share.  An Option will be deemed exercised when the Company receives: (a) notice of exercise (in such form as the Committee may specify from time to time) from the person entitled to exercise the Option (and/or via electronic execution through the authorized third party administrator), and (b) full payment for the Shares with respect to which the Option is exercised (together with applicable withholding taxes). Full payment may consist of any consideration and method of payment authorized by the Committee and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares, notwithstanding the 
4
        

exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised.  No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 2.6 of the Plan. Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.
5.6.Termination of Service.  If the Participant’s Service terminates for any reason except for Cause or the Participant’s death or Disability, then the Participant may exercise such Participant’s Options only to the extent that such Options would have been exercisable by the Participant on the date Participant’s Service terminates no later than three (3) months after the date Participant’s Service terminates (or such shorter time period not less than thirty (30) days or longer time period as may be determined by the Committee, with any exercise beyond three (3) months after the date Participant’s Service terminates deemed to be the exercise of an NSO), but in any event no later than the expiration date of the Options. 
(a)Death.  If the Participant’s Service terminates because of the Participant’s death (or the Participant dies within three (3) months after Participant’s Service terminates other than for Cause or because of the Participant’s Disability), then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant’s Service terminates and must be exercised by the Participant’s legal representative, or authorized assignee, no later than twelve (12) months after the date Participant’s Service terminates (or such shorter time period not less than six (6) months or longer time period as may be determined by the Committee), but in any event no later than the expiration date of the Options. 
(b)Disability.  If the Participant’s Service terminates because of the Participant’s Disability, then the Participant’s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant’s Service terminates and must be exercised by the Participant (or the Participant’s legal representative or authorized assignee) no later than twelve (12) months after the date Participant’s Service terminates (or such shorter time period not less than six (6) months or longer time period as may be determined by the Committee, with any exercise beyond (a) three (3) months after the date Participant’s Service terminates when the termination of Service is for a Disability that is not a “permanent and total disability” as defined in Section 22(e)(3) of the Code, or (b) twelve (12) months after the date Participant’s Service terminates when the termination of Service is for a Disability that is a “permanent and total disability” as defined in Section 22(e)(3) of the Code, deemed to be exercise of an NSO), but in any event no later than the expiration date of the Options. 
(c)Cause.  If the Participant’s Service terminates for Cause, then Participant’s Options will expire on the date of termination of Participant’s Service, or at such later time and on such conditions as are determined by the Committee, but in any event no later than the expiration date of the Options.  Unless otherwise provided in an employment agreement, Award Agreement, or other applicable agreement, Cause will have the meaning set forth in the Plan.  
5.7.Limitations on Exercise.  The Committee may specify a minimum number of Shares that may be purchased on any exercise of an Option, provided that such minimum number will not prevent any Participant from exercising the Option for the full number of Shares for which it is then exercisable.
5.8.Limitations on ISOs.  With respect to Awards granted as ISOs, to the extent that the aggregate Fair Market Value of the Shares with respect to which such ISOs are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as NSOs. For purposes of this Section 5.8, ISOs will be taken into account in the order in which they were granted. The Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted.  In the event that the Code or the regulations promulgated thereunder are amended after the Effective Date to provide for a different limit on the Fair Market Value of Shares permitted to be subject to ISOs, such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.
5
        

5.9.Modification, Extension or Renewal.  The Committee may modify, extend, or renew outstanding Options and authorize the grant of new Options in substitution therefor, provided that any such action may not, without the written consent of a Participant, impair any of such Participant’s rights under any Option previously granted.  Any outstanding ISO that is modified, extended, renewed, or otherwise altered will be treated in accordance with Section 424(h) of the Code.  Subject to Section 18 of this Plan, by written notice to affected Participants, the Committee may reduce the Exercise Price of outstanding Options without the consent of such Participants; provided, however, that the Exercise Price may not be reduced below the Fair Market Value on the date the action is taken to reduce the Exercise Price.
5.10.No Disqualification.  Notwithstanding any other provision in this Plan, no term of this Plan relating to ISOs will be interpreted, amended, or altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section 422 of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.
6.RESTRICTED STOCK AWARDS.  A Restricted Stock Award is an offer by the Company to sell to an eligible Employee, Consultant, or Director Shares that are subject to restrictions (“Restricted Stock”).  The Committee will determine to whom an offer will be made, the number of Shares the Participant may purchase, the Purchase Price, the restrictions under which the Shares will be subject, and all other terms and conditions of the Restricted Stock Award, subject to the Plan.  
6.1.Restricted Stock Purchase Agreement.  All purchases under a Restricted Stock Award will be evidenced by an Award Agreement.  Except as may otherwise be provided in an Award Agreement, a Participant accepts a Restricted Stock Award by signing and delivering to the Company an Award Agreement with full payment of the Purchase Price, within thirty (30) days from the date the Award Agreement was delivered to the Participant.  If the Participant does not accept such Award within thirty (30) days, then the offer of such Restricted Stock Award will terminate, unless the Committee determines otherwise.  
6.2.Purchase Price.  The Purchase Price for a Restricted Stock Award will be determined by the Committee and may be less than Fair Market Value on the date the Restricted Stock Award is granted.  Payment of the Purchase Price must be made in accordance with Section 11 of the Plan, and the Award Agreement and in accordance with any procedures established by the Company.
6.3.Terms of Restricted Stock Awards.  Restricted Stock Awards will be subject to such restrictions as the Committee may impose or are required by law.  These restrictions may be based on completion of a specified number of years of service with the Company or upon completion of Performance Factors, if any, during any Performance Period as set out in advance in the Participant’s Award Agreement.  Prior to the grant of a Restricted Stock Award, the Committee will: (a) determine the nature, length, and starting date of any Performance Period for the Restricted Stock Award; (b) select from among the Performance Factors to be used to measure performance goals, if any; and (c) determine the number of Shares that may be awarded to the Participant.  Performance Periods may overlap and a Participant may participate simultaneously with respect to Restricted Stock Awards that are subject to different Performance Periods and having different performance goals and other criteria.
6.4.Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date Participant’s Service terminates (unless determined otherwise by the Committee). 
7.STOCK BONUS AWARDS.  A Stock Bonus Award is an award to an eligible Employee, Consultant, or Director of Shares for Services to be rendered or for past Services already rendered to the Company or any Parent, Subsidiary, or Affiliate.  All Stock Bonus Awards will be made pursuant to an Award Agreement.  No payment from the Participant will be required for Shares awarded pursuant to a Stock Bonus Award.  
7.1.Terms of Stock Bonus Awards.  The Committee will determine the number of Shares to be awarded to the Participant under a Stock Bonus Award and any restrictions thereon.  These restrictions may be based upon completion of a specified number of years of service with the Company or upon 
6
        

satisfaction of performance goals based on Performance Factors during any Performance Period as set out in advance in the Participant’s Stock Bonus Agreement.  Prior to the grant of any Stock Bonus Award the Committee will: (a) determine the nature, length, and starting date of any Performance Period for the Stock Bonus Award; (b) select from among the Performance Factors to be used to measure performance goals; and (c) determine the number of Shares that may be awarded to the Participant.  Performance Periods may overlap and a Participant may participate simultaneously with respect to Stock Bonus Awards that are subject to different Performance Periods and different performance goals and other criteria.  
7.2.Form of Payment to Participant.  Payment may be made in the form of cash, whole Shares, or a combination thereof, based on the Fair Market Value of the Shares earned under a Stock Bonus Award on the date of payment, as determined in the sole discretion of the Committee.  
7.3.Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date Participant’s Service terminates (unless determined otherwise by the Committee). 
8.STOCK APPRECIATION RIGHTS.  A Stock Appreciation Right (“SAR”) is an award to an eligible Employee, Consultant, or Director that may be settled in cash or Shares (which may consist of Restricted Stock) having a value equal to (a) the difference between the Fair Market Value on the date of exercise over the Exercise Price multiplied by (b) the number of Shares with respect to which the SAR is being settled (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement).  All SARs will be made pursuant to an Award Agreement. 
8.1.Terms of SARs.  The Committee will determine the terms of each SAR including, without limitation: (a) the number of Shares subject to the SAR, (b) the Exercise Price and the time or times during which the SAR may be settled, (c) the consideration to be distributed on settlement of the SAR, and (d) the effect of the Participant’s termination of Service on each SAR.  The Exercise Price of the SAR will be determined by the Committee when the SAR is granted and may not be less than Fair Market Value on the date of grant.  A SAR may be awarded upon satisfaction of Performance Factors, if any, during any Performance Period as are set out in advance in the Participant’s individual Award Agreement.  If the SAR is being earned upon the satisfaction of Performance Factors, then the Committee will: (i) determine the nature, length, and starting date of any Performance Period for each SAR; and (ii) select from among the Performance Factors to be used to measure the performance, if any.  Performance Periods may overlap and Participants may participate simultaneously with respect to SARs that are subject to different Performance Factors and other criteria.
8.2.Exercise Period and Expiration Date.  A SAR will be exercisable within the times or upon the occurrence of events determined by the Committee and set forth in the Award Agreement governing such SAR.  The SAR Agreement will set forth the expiration date; provided that no SAR will be exercisable after the expiration of ten (10) years from the date the SAR is granted.  The Committee may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of the Shares subject to the SAR as the Committee determines.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on the date Participant’s Service terminates (unless determined otherwise by the Committee).  Notwithstanding the foregoing, the rules of Section 5.6 also will apply to SARs.
8.3.Form of Settlement.  Upon exercise of a SAR, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying (a) the difference between the Fair Market Value of a Share on the date of exercise over the Exercise Price, times (b) the number of Shares with respect to which the SAR is exercised. At the discretion of the Committee, the payment from the Company for the SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof.  The portion of a SAR being settled may be paid currently or on a deferred basis with such interest or Dividend Equivalent Right, if any, as the Committee determines, provided that the terms of the SAR and any deferral satisfy the requirements of Section 409A of the Code to the extent applicable.
7
        

8.4.Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date Participant’s Service terminates (unless determined otherwise by the Committee).
9.RESTRICTED STOCK UNITS.  A Restricted Stock Unit (“RSU”) is an award to an eligible Employee, Consultant, or Director covering a number of Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock).  All RSUs will be made pursuant to an Award Agreement.
9.1.Terms of RSUs.  The Committee will determine the terms of an RSU including, without limitation: (a) the number of Shares subject to the RSU, (b) the time or times during which the RSU may be settled, (c) the consideration to be distributed on settlement, and (d) the effect of the Participant’s termination of Service on each RSU; provided that no RSU will have a term longer than ten (10) years.  An RSU may be awarded upon satisfaction of such performance goals based on Performance Factors during any Performance Period as are set out in advance in the Participant’s Award Agreement.  If the RSU is being earned upon satisfaction of Performance Factors, then the Committee will: (i) determine the nature, length, and starting date of any Performance Period for the RSU; (ii) select from among the Performance Factors to be used to measure the performance, if any; and (iii) determine the number of Shares deemed subject to the RSU.  Performance Periods may overlap and Participants may participate simultaneously with respect to RSUs that are subject to different Performance Periods and different performance goals and other criteria.  
9.2.Form and Timing of Settlement.  Payment of earned RSUs will be made as soon as practicable after the date(s) determined by the Committee and set forth in the Award Agreement. The Committee, in its sole discretion, may settle earned RSUs in cash, Shares, or a combination of both.  The Committee may also permit a Participant to defer payment under a RSU to a date or dates after the RSU is earned provided that the terms of the RSU and any deferral satisfy the requirements of Section 409A of the Code.
9.3.Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on such date Participant’s Service terminates (unless determined otherwise by the Committee).
10.PERFORMANCE AWARDS.  A Performance Award is an award to an eligible Employee, Consultant, or Director of the Company or any Parent, Subsidiary, or Affiliate that is based upon the attainment of performance goals, as established by the Committee, and other terms and conditions specified by the Committee, and may be settled in cash, Shares (which may consist of, without limitation, Restricted Stock), other property, or any combination thereof.  Grants of Performance Awards will be made pursuant to an Award Agreement.
10.1.Types of Performance Awards. Performance Awards will include Performance Shares, Performance Units, and cash-based Awards as set forth in Sections 10.1(a), 10.1(b), and 10.1(c) below. 
(a)Performance Shares.  The Committee may grant Awards of Performance Shares, designate the Participants to whom Performance Shares are to be awarded, and determine the number of Performance Shares and the terms and conditions of each such Award. Performance Shares shall consist of a unit valued by reference to a designated number of Shares, the value of which may be paid to the Participant by delivery of Shares or, if set forth in the instrument evidencing the Award, of such property as the Committee shall determine, including, without limitation, cash, Shares, other property, or any combination thereof, upon the attainment of performance goals, as established by the Committee, and other terms and conditions specified by the Committee. The amount to be paid under an Award of Performance Shares may be adjusted on the basis of such further consideration as the Committee shall determine in its sole discretion. 
(b)Performance Units.  The Committee may grant Awards of Performance Units, designate the Participants to whom Performance Units are to be awarded, and determine the number of Performance Units and the terms and conditions of each such Award. Performance Units shall consist of a unit valued by reference to a designated amount of property other than Shares, which value may be paid 
8
        

to the Participant by delivery of such property as the Committee shall determine, including, without limitation, cash, Shares, other property, or any combination thereof, upon the attainment of performance goals, as established by the Committee, and other terms and conditions specified by the Committee. 
(c)Cash-Settled Performance Awards.  The Committee may also grant cash-based Performance Awards to Participants under the terms of this Plan. Such awards will be based on the attainment of performance goals using the Performance Factors within this Plan that are established by the Committee for the relevant performance period. 
10.2.Terms of Performance Awards.  Performance Awards will be based on the attainment of performance goals using the Performance Factors within this Plan that are established by the Committee for the relevant performance period.  The Committee will determine, and each Award Agreement will set forth, the terms of each Performance Award including, without limitation: (a) the amount of any cash bonus, (b) the number of Shares deemed subject to an award of Performance Shares, (c) the Performance Factors and Performance Period that will determine the time and extent to which each award of Performance Shares will be settled, (d) the consideration to be distributed on settlement, and (e) the effect of the Participant’s termination of Service on each Performance Award.  In establishing Performance Factors and the Performance Period the Committee will: (i) determine the nature, length, and starting date of any Performance Period; (ii) select from among the Performance Factors to be used; and (iii) determine the number of Shares deemed subject to the award of Performance Shares.  Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.  Prior to settlement the Committee will determine the extent to which Performance Awards have been earned.  Performance Periods may overlap and Participants may participate simultaneously with respect to Performance Awards that are subject to different Performance Periods and different performance goals and other criteria.  
10.3.Termination of Service.  Except as may be set forth in the Participant’s Award Agreement, vesting ceases on the date Participant’s Service terminates (unless determined otherwise by the Committee).
11.PAYMENT FOR SHARE PURCHASES.  Payment from a Participant for Shares purchased pursuant to this Plan may be made in cash or by check or, where expressly approved for the Participant by the Committee and where permitted by law (and to the extent not otherwise set forth in the applicable Award Agreement): 
(a)by cancellation of indebtedness of the Company to the Participant;
(b)by surrender of shares of the Company held by the Participant that have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Award will be exercised or settled;
(c)by waiver of compensation due or accrued to the Participant for services rendered or to be rendered to the Company or a Parent or Subsidiary;
(d)by consideration received by the Company pursuant to a broker-assisted or other form of cashless exercise program implemented by the Company in connection with the Plan; 
(e)by any combination of the foregoing; or
(f)by any other method of payment as is permitted by applicable law.
The Committee may limit the availability of any method of payment, to the extent the Committee determines, in its discretion, such limitation is necessary or advisable to comply with applicable law or facilitate the administration of the Plan.
12.GRANTS TO NON-EMPLOYEE DIRECTORS. Non-Employee Directors are eligible to receive any type of Award offered under this Plan except ISOs.  Awards pursuant to this Section 12 may be automatically made pursuant to policy adopted by the Board, or made from time to time as determined 
9
        

in the discretion of the Board.  No Non-Employee Director may receive Awards under the Plan that, when combined with cash compensation received for service as a Non-Employee Director, exceeds $750,000 in value (as described below) in any calendar year, increased to $1,000,000 in value (as described below) in the calendar year of his or her initial services as a Non-Employee Director.  The value of Awards for purposes of complying with this maximum shall be determined as follows:  (a) for Options and SARs, grant date fair value will be calculated using the Black-Scholes valuation methodology on the date of grant of such Option or SAR, and (b) for all other Awards other than Options and SARs, grant date fair value will be determined by either (i) calculating the product of the Fair Market Value per Share on the date of grant and the aggregate number of Shares subject to the Award, or (ii) calculating the product using an average of the Fair Market Value over a number of trading days and the aggregate number of Shares subject to the Award as determined by the Committee.  Awards granted to an individual while he or she was serving in the capacity as an Employee or while he or she was a Consultant but not a Non-Employee Director will not count for purposes of the limitations set forth in this Section 12.1.
12.1.Eligibility.  Awards pursuant to this Section 12 will be granted only to Non-Employee Directors.  A Non-Employee Director who is elected or re-elected as a member of the Board will be eligible to receive an Award under this Section 12.
12.2.Vesting, Exercisability and Settlement.  Except as set forth in Section 21, Awards will vest, become exercisable, and be settled as determined by the Board.  With respect to Options and SARs, the exercise price granted to Non-Employee Directors will not be less than the Fair Market Value of the Shares at the time that such Option or SAR is granted.
12.3.Election to Receive Awards in Lieu of Cash.  A Non-Employee Director may elect to receive his or her annual retainer payments and/or meeting fees from the Company in the form of cash or Awards or a combination thereof, as determined by the Committee.  Such Awards will be issued under the Plan.  An election under this Section 12.3 will be filed with the Company on the form prescribed by the Company.
13.WITHHOLDING TAXES.
13.1.Withholding Generally.  Whenever Shares are to be issued in satisfaction of Awards granted under this Plan or a tax event occurs, the Company may require the Participant to remit to the Company, or to the Parent, Subsidiary, or Affiliate, as applicable, employing the Participant an amount sufficient to satisfy applicable U.S. federal, state, local, and international tax or any other tax or social insurance liability (the “Tax-Related Items”) required to be withheld from the Participant prior to the delivery of Shares pursuant to exercise or settlement of any Award.  Whenever payments in satisfaction of Awards granted under this Plan are to be made in cash, such payment will be net of an amount sufficient to satisfy applicable withholding obligations for Tax-Related Items.  Unless otherwise determined by the Committee, the Fair Market Value of the Shares will be determined as of the date that the taxes are required to be withheld and such Shares will be valued based on the value of the actual trade or, if there is none, the Fair Market Value of the Shares as of the previous trading day.
13.2.Stock Withholding.  The Committee, or its delegate(s), as permitted by applicable law, in its sole discretion and pursuant to such procedures as it may specify from time to time and to limitations of local law, may require or permit a Participant to satisfy such Tax Related Items legally due from the Participant, in whole or in part by (without limitation) (a) paying cash, (b) having the Company withhold otherwise deliverable cash or Shares having a Fair Market Value equal to the Tax-Related Items to be withheld, (c) delivering to the Company already-owned shares having a Fair Market Value equal to the Tax-Related Items to be withheld, or (d) withholding from the proceeds of the sale of otherwise deliverable Shares acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company.  The Company may withhold or account for these Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including up to the maximum permissible statutory tax rate for the applicable tax jurisdiction, to the extent consistent with applicable laws.    
14.TRANSFERABILITY.  
10
        

14.1.Transfer Generally.  Unless determined otherwise by the Committee or pursuant to Section 14.2, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution.  If the Committee makes an Award transferable, including, without limitation, by instrument to an inter vivos or testamentary trust in which the Awards are to be passed to beneficiaries upon the death of the trustor (settlor) or by gift or by domestic relations order to a Permitted Transferee, such Award will contain such additional terms and conditions as the Committee deems appropriate.  All Awards will be exercisable: (a) during the Participant’s lifetime only by the Participant or the Participant’s guardian or legal representative; (b) after the Participant’s death, by the legal representative of the Participant’s heirs or legatees; and (c) in the case of all awards except ISOs, by a Permitted Transferee.
14.2.Award Transfer Program.  Notwithstanding any contrary provision of the Plan, the Committee will have all discretion and authority to determine and implement the terms and conditions of any Award Transfer Program instituted pursuant to this Section 14.2 and will have the authority to amend the terms of any Award participating, or otherwise eligible to participate in, the Award Transfer Program, including (but not limited to) the authority to (a) amend (including to extend) the expiration date, post-termination exercise period, and/or forfeiture conditions of any such Award; (b) amend or remove any provisions of the Award relating to the Award holder’s continued Service to the Company or any  Parent, Subsidiary, or Affiliate; (c) amend the permissible payment methods with respect to the exercise or purchase of any such Award; (d) amend the adjustments to be implemented in the event of changes in the capitalization of the Company and other similar events with respect to such Award; and (e) make such other changes to the terms of such Award as the Committee deems necessary or appropriate in its sole discretion.
15.PRIVILEGES OF STOCK OWNERSHIP; RESTRICTIONS ON SHARES.
15.1.Voting and Dividends.  No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued to the Participant, except for any Dividend Equivalent Rights permitted by an applicable Award Agreement. Any Dividend Equivalent Rights will be subject to the same vesting or performance conditions as the underlying Award.  In addition, the Committee may provide that any Dividend Equivalent Rights permitted by an applicable Award Agreement will be deemed to have been reinvested in additional Shares or otherwise reinvested. After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid with respect to such Shares; provided, that if such Shares are Restricted Stock, then any new, additional, or different securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split, or any other change in the corporate or capital structure of the Company will be subject to the same restrictions as the Restricted Stock; provided, further, that the Participant will have no right to retain such stock dividends or stock distributions with respect to Shares that are repurchased at the Participant’s Purchase Price or Exercise Price, as the case may be, pursuant to Section 15.2.  The Committee, in its discretion, may provide in any Award Agreement that the Participant will be entitled to Dividend Equivalent Rights with respect to the payment of cash dividends on Shares underlying an Award during the period beginning on the date the Award is granted and ending, with respect to each Share subject to the Award, on the earlier of the date on which the Award is exercised or settled or the date on which it is forfeited. Such Dividend Equivalent Rights, if any, will be credited to the Participant in the form of additional whole Shares as of the date of payment of such cash dividends on Shares.  Notwithstanding the foregoing, dividends and Dividend Equivalent Rights may accrue with respect to unvested Awards, but will not be paid or issued until such Award is fully vested and the Shares are issued to Participant and such Shares are no longer subject to any vesting requirements or repurchase rights on behalf of the Company.
15.2.Restrictions on Shares.  At the discretion of the Committee, the Company may reserve to itself and/or its assignee(s) a right to repurchase (a “Right of Repurchase”) a portion of any or all Unvested Shares held by a Participant following such Participant’s termination of Service at any time within ninety (90) days (or such longer or shorter time determined by the Committee) after the later of the date Participant’s Service terminates and the date the Participant purchases Shares under this Plan, for cash and/or cancellation of purchase money indebtedness, at the Participant’s Purchase Price or Exercise Price, as the case may be.
11
        

16.CERTIFICATES.  All Shares or other securities whether or not certificated, delivered under this Plan will be subject to such stock transfer orders, legends, and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable U.S. federal, state, or foreign securities law, or any rules, regulations, and other requirements of the SEC or any stock exchange or automated quotation system upon which the Shares may be listed or quoted, and any non-U.S. exchange controls or securities law restrictions to which the Shares are subject.
17.ESCROW; PLEDGE OF SHARES.  To enforce any restrictions on a Participant’s Shares, the Committee may require the Participant to deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates.  Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of the Participant’s obligation to the Company under the promissory note; provided, however, that the Committee may require or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory note notwithstanding any pledge of the Participant’s Shares or other collateral.  In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will from time to time approve.  The Shares purchased with the promissory note may be released from the pledge on a pro rata basis as the promissory note is paid.
18.REPRICING; EXCHANGE AND BUYOUT OF AWARDS.  Without prior stockholder approval the Committee may (a) reprice Options or SARs (and where such repricing is a reduction in the Exercise Price of outstanding Options or SARs, the consent of the affected Participants is not required provided written notice is provided to them, notwithstanding any adverse tax consequences to them arising from the repricing), and (b) with the consent of the respective Participants (unless not required pursuant to Section 5.9 of the Plan), pay cash or issue new Awards in exchange for the surrender and cancellation of any, or all, outstanding Awards.
19.SECURITIES LAW AND OTHER REGULATORY COMPLIANCE.  An Award will not be effective unless such Award is in compliance with all applicable U.S. and foreign federal and state securities and exchange control laws, rules, and regulations of any governmental body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as they are in effect on the date of grant of the Award and also on the date of exercise or other issuance.  Notwithstanding any other provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to: (a) obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and/or (b) completion of any registration or other qualification of such Shares under any state, federal, or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable.  The Company will be under no obligation to register the Shares with the SEC or to effect compliance with the registration, qualification, or listing requirements of any foreign or state securities laws, exchange control laws, stock exchange, or automated quotation system, and the Company will have no liability for any inability or failure to do so.
20.NO OBLIGATION TO EMPLOY.  Nothing in this Plan or any Award granted under this Plan will confer or be deemed to confer on any Participant any right to continue in the employ of, or to continue any other relationship with, the Company or any Parent, Subsidiary, or Affiliate or limit in any way the right of the Company or any Parent, Subsidiary, or Affiliate to terminate Participant’s employment or other relationship at any time.
21.CORPORATE TRANSACTIONS.
21.1.Assumption or Replacement of Awards by Successor.  In the event of a Corporate Transaction any or all outstanding Awards may be assumed, converted, replaced, or substituted by the successor corporation, which will be binding on all Participants.  In the event of a substitution, the successor corporation may substitute equivalent Awards or provide substantially similar consideration to 
12
        

Participants as was provided to stockholders (after taking into account the existing provisions of the Awards).  The successor corporation may also issue, as replacement of outstanding Shares of the Company held by the Participant, substantially similar shares or other property subject to repurchase restrictions no less favorable to the Participant.  In the event such successor or acquiring corporation (if any) refuses to assume, convert, replace, or substitute Awards, as provided above, pursuant to a Corporate Transaction, then notwithstanding any other provision in this Plan to the contrary, such Awards will have their vesting accelerate as to all shares subject to such Award (and any applicable right of repurchase fully lapse) immediately prior to the Corporate Transaction.  In addition, in the event such successor or acquiring corporation (if any) refuses to assume, convert, replace, or substitute Awards, as provided above, pursuant to a Corporate Transaction, the Committee will notify the Participant in writing or electronically that such Award will be exercisable for a period of time determined by the Committee in its sole discretion, and such Award will terminate upon the expiration of such period.  Awards need not all be treated in the same manner in a Corporate Transaction, and treatment may vary from Award to Award and/or from Participant to Participant. 
21.2.Assumption of Awards by the Company.  The Company, from time to time, also may substitute or assume outstanding awards granted by another company, whether in connection with an acquisition of such other company or otherwise, by either: (a) granting an Award under this Plan in substitution of such other company’s award, or (b) assuming such award as if it had been granted under this Plan if the terms of such assumed award could be applied to an Award granted under this Plan.  Such substitution or assumption will be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the other company had applied the rules of this Plan to such grant.  In the event the Company assumes an award granted by another company, the terms and conditions of such award will remain unchanged (except that the Purchase Price or the Exercise Price, as the case may be, and the number and nature of Shares issuable upon exercise or settlement of any such Award will be adjusted appropriately pursuant to Section 424(a) of the Code).  In the event the Company elects to grant a new Option in substitution rather than assuming an existing option, such new Option may be granted with a similarly adjusted Exercise Price.  Substitute Awards will not reduce the number of Shares authorized for grant under the Plan or authorized for grant to a Participant in a calendar year.
21.3.Non-Employee Directors’ Awards.  Notwithstanding any provision to the contrary herein, in the event of a Corporate Transaction, the vesting of all Awards granted to Non-Employee Directors will accelerate and such Awards will become exercisable (as applicable) in full prior to the consummation of such event at such times and on such conditions as the Committee determines.
22.ADOPTION AND STOCKHOLDER APPROVAL.  This Plan will be submitted for the approval of the Company’s stockholders, consistent with applicable laws, within twelve (12) months before or after the date this Plan is adopted by the Board.  
23.TERM OF PLAN/GOVERNING LAW.  Unless earlier terminated as provided herein, this Plan will become effective on the Effective Date and will terminate ten (10) years from the date this Plan is adopted by the Board.  This Plan and all Awards granted hereunder will be governed by and construed in accordance with the laws of the State of Washington (excluding its conflict of laws rules).
24.AMENDMENT OR TERMINATION OF PLAN.  The Board may at any time terminate or amend this Plan in any respect, including, without limitation, amendment of any form of Award Agreement or instrument to be executed pursuant to this Plan; provided, however, that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder approval; provided further, that a Participant’s Award shall be governed by the version of this Plan then in effect at the time such Award was granted.  No termination or amendment of the Plan will affect any then-outstanding Award unless expressly provided by the Committee.  In any event, no termination or amendment of the Plan or any outstanding Award may adversely affect any then outstanding Award without the consent of the Participant, unless such termination or amendment is necessary to comply with applicable law, regulation, or rule.
25.NONEXCLUSIVITY OF THE PLAN.  Neither the adoption of this Plan by the Board, the submission of this Plan to the stockholders of the Company for approval, nor any provision of this Plan 
13
        

will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of stock awards and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases.
26.INSIDER TRADING POLICY.  Each Participant who receives an Award will comply with any policy adopted by the Company from time to time covering transactions in the Company’s securities by Employees, officers, and/or Directors of the Company, as well as with any applicable insider trading or market abuse laws to which the Participant may be subject.
27.ALL AWARDS SUBJECT TO COMPANY CLAWBACK OR RECOUPMENT POLICY.  All Awards, subject to applicable law, will be subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law during the term of Participant’s employment or other service with the Company that is applicable to officers, Employees, Directors or other service providers of the Company, and in addition to any other remedies available under such policy and applicable law, may require the cancellation of outstanding Awards and the recoupment of any gains realized with respect to Awards.
28.DEFINITIONS.  As used in this Plan, and except as elsewhere defined herein, the following terms will have the following meanings:
28.1.“Affiliate” means (a) any entity that, directly or indirectly, is controlled by, controls, or is under common control with, the Company, and (b) any entity in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing. 
28.2.“Award” means any award under the Plan, including any Option, Performance Award, Restricted Stock, Stock Bonus, Stock Appreciation Right, or Restricted Stock Unit.
28.3.“Award Agreement” means, with respect to each Award, the written or electronic agreement between the Company and the Participant setting forth the terms and conditions of the Award, and country-specific appendix thereto for grants to non-U.S. Participants, which will be in substantially a form (which need not be the same for each Participant) that the Committee (or in the case of Award agreements that are not used for Insiders, the Committee’s delegate(s)) has from time to time approved, and will comply with and be subject to the terms and conditions of this Plan.
28.4.“Award Transfer Program” means any program instituted by the Committee which would permit Participants the opportunity to transfer any outstanding Awards to a financial institution or other person or entity approved by the Committee.
28.5.“Board” means the Board of Directors of the Company.
28.6.“Cause” means Termination because of Participant’s commission of any act of fraud, embezzlement, or dishonesty; any unauthorized use or disclosure of confidential information or trade secrets of the Company (or any Parent, Subsidiary, or Affiliate); Participant’s conviction of or plea of nolo contendere to a felony or a crime involving moral turpitude; or any intentional misconduct by Participant adversely affecting the business or affairs of the Company (or any Parent, Subsidiary, or Affiliate) in any material manner.  The determination as to whether a Participant is being terminated for Cause will be made in good faith by the Company and will be final and binding on the Participant.  This definition will not restrict in any way the Company’s or any Parent’s, Subsidiary’s, or Affiliate’s right to discharge Participant for any other reason, nor will this definition be deemed to be inclusive of all the acts or omissions which constitute “Cause” for purposes other than this Plan.  Notwithstanding the foregoing, the foregoing definition of “Cause” may, in part or in whole, be modified or replaced in each individual employment agreement, Award Agreement, or other applicable agreement with any Participant, provided that such document supersedes the definition provided in this Section 28.6.  
28.7.“Code” means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.
14
        

28.8.“Committee” means the Compensation Committee of the Board or those persons to whom administration of the Plan, or part of the Plan, has been delegated as permitted by law.  
28.9.“Common Stock” means the Class A common stock of the Company.
28.10.“Company” means Smartsheet Inc., a Washington corporation, or any successor corporation.
28.11.“Consultant” means any natural person, including an advisor or independent contractor, engaged by the Company or a Parent, Subsidiary, or Affiliate to render services to such entity.
28.12.“Corporate Transaction” means the occurrence of any of the following events: (a) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then-outstanding voting securities; provided, however, that for purposes of this subclause (a) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction; (b) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (d) any other transaction which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of capital stock of the Company), or (e) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purpose of this subclause (e), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction.  For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction with the Company.  Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount will become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.  
28.13.“Director” means a member of the Board. 
28.14.“Disability” means in the case of incentive stock options, total and permanent disability as defined in Section 22(e)(3) of the Code and in the case of other Awards, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months.  
28.15.“Dividend Equivalent Right” means the right of a Participant, granted at the discretion of the Committee or as otherwise provided by the Plan, to receive a credit for the account of such Participant in an amount equal to the cash, stock, or other property dividends in amounts equal equivalent to cash, stock, or other property dividends for each Share represented by an Award held by such Participant.
15
        

28.16.“Effective Date” means the day immediately prior to the date of the underwritten initial public offering of the Company’s common stock pursuant to a registration statement that is declared effective by the SEC.
28.17.“Employee” means any person, including officers and Directors, providing services as an employee to the Company or any Parent, Subsidiary, or Affiliate. Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company.
28.18.“Exchange Act” means the United States Securities Exchange Act of 1934, as amended.
28.19.“Exchange Program” means a program pursuant to which (a) outstanding Awards are surrendered, cancelled, or exchanged for cash, the same type of Award, or a different Award (or combination thereof); or (b) the exercise price of an outstanding Award is increased or reduced.
28.20.“Exercise Price” means, with respect to an Option, the price at which a holder may purchase the Shares issuable upon exercise of an Option and with respect to a SAR, the price at which the SAR is granted to the holder thereof.
28.21.“Fair Market Value” means, as of any date, the value of a share of the Company’s Common Stock determined as follows:
(a)if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in The Wall Street Journal or such other source as the Committee deems reliable;
(b)if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Committee deems reliable;
(c)in the case of an Option or SAR grant made on the Effective Date, the price per share at which Shares are initially offered for sale to the public by the Company’s underwriters in the initial public offering of the Company’s Common Stock pursuant to a registration statement filed with the SEC under the Securities Act; or
(d)if none of the foregoing is applicable, by the Board or the Committee in good faith.
28.22.“Insider” means an officer or Director of the Company or any other person whose transactions in the Company’s Common Stock are subject to Section 16 of the Exchange Act.
28.23.“IRS” means the United States Internal Revenue Service.
28.24.“Non-Employee Director” means a Director who is not an Employee of the Company or any Parent, Subsidiary, or Affiliate.
28.25. “Option” means an award of an option to purchase Shares pursuant to Section 5.
28.26.“Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.
28.27.“Participant” means a person who holds an Award under this Plan.  
16
        

28.28.“Performance Award” means cash or Shares granted pursuant to Section 10 or Section 12 of the Plan.
28.29.“Performance Factors” means any of the factors selected by the Committee and specified in an Award Agreement, from among the following measures, either individually, alternatively or in any combination, applied to the Company as a whole or any business unit or Subsidiary, either individually, alternatively, or in any combination, on a GAAP or non-GAAP basis, and measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance goals established by the Committee with respect to applicable Awards have been satisfied: 
(a)profit before tax;
(b)billings;
(c)revenue; 
(d)net revenue; 
(e)earnings (which may include earnings before interest and taxes, earnings before taxes, net earnings, stock-based compensation expenses, depreciation, and amortization); 
(f)operating income; 
(g)operating margin; 
(h)operating profit; 
(i)controllable operating profit or net operating profit; 
(j)net profit; 
(k)gross margin; 
(l)operating expenses or operating expenses as a percentage of revenue; 
(m) net income; 
(n)earnings per share; 
(o)total stockholder return; 
(p)market share; 
(q)return on assets or net assets; 
(r)the Company’s stock price; 
(s)growth in stockholder value relative to a pre-determined index; 
(t)return on equity; 
(u)return on invested capital; 
(v)cash flow (including free cash flow or operating cash flows); 
(w)cash conversion cycle; 
17
        

(x)economic value added;  
(y)individual confidential business objectives; 
(z)contract awards or backlog; 
(aa)overhead or other expense reduction; 
(bb)    credit rating; 
(cc)    strategic plan development and implementation; 
(dd)    succession plan development and implementation; 
(ee)    improvement in workforce diversity; 
(ff)    customer indicators and/or satisfaction; 
(gg)    new product invention or innovation; 
(hh)    attainment of research and development milestones; 
(ii)    improvements in productivity; 
(jj)    bookings;
(kk)    attainment of objective operating goals and employee metrics; 
(ll)    sales;
(mm)    expenses; 
(nn)    balance of cash, cash equivalents, and marketable securities;
(oo)    completion of an identified special project;
(pp)    completion of a joint venture or other corporate transaction;
(qq)    employee satisfaction and/or retention;
(rr)    research and development expenses;
(ss)    working capital targets and changes in working capital; and 
(tt)    any other metric that is capable of measurement as determined by the Committee.  
The Committee may, in recognition of unusual or non-recurring items such as acquisition-related activities or changes in applicable accounting rules, provide for one or more equitable adjustments (based on objective standards) to the Performance Factors to preserve the Committee’s original intent regarding the Performance Factors at the time of the initial award grant.  It is within the sole discretion of the Committee to make or not make any such equitable adjustments.
28.30.“Performance Period” means one or more periods of time, which may be of varying and overlapping durations, as the Committee may select, over which the attainment of one or more Performance Factors will be measured for the purpose of determining a Participant’s right to, and the payment of, a Performance Award. 
18
        

28.31.“Performance Share” means an Award as defined in Section 10 and granted under the Plan. 
28.32.“Performance Unit” means an Award as defined in Section 10 and granted under the Plan. 
28.33. “Permitted Transferee” means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including adoptive relationships) of the Employee, any person sharing the Employee’s household (other than a tenant or employee), a trust in which these persons (or the Employee) have more than 50% of the beneficial interest, a foundation in which these persons (or the Employee) control the management of assets, and any other entity in which these persons (or the Employee) own more than 50% of the voting interests.
28.34.“Plan” means this Smartsheet Inc. 2018 Equity Incentive Plan.
28.35.“Purchase Price” means the price to be paid for Shares acquired under the Plan, other than Shares acquired upon exercise of an Option or SAR. 
28.36.“Restricted Stock Award” means an Award as defined in Section 6 and granted under the Plan, or issued pursuant to the early exercise of an Option. 
28.37.“Restricted Stock Unit” means an Award as defined in Section 9 and granted under the Plan. 
28.38. “SEC” means the United States Securities and Exchange Commission.
28.39.“Securities Act” means the United States Securities Act of 1933, as amended.
28.40.“Service” will mean service as an Employee, Consultant, Director, or Non-Employee Director, to the Company or a Parent, Subsidiary, or Affiliate, subject to such further limitations as may be set forth in the Plan or the applicable Award Agreement.  An Employee will not be deemed to have ceased to provide Service in the case of (a) sick leave, (b) military leave, or (c) any other leave of absence approved by the Company; provided, that such leave is for a period of not more than ninety (90) days unless reemployment upon the expiration of such leave is guaranteed by contract or statute.  Notwithstanding anything to the contrary, an Employee will not be deemed to have ceased to provide Service if a formal policy adopted from time to time by the Company and issued and promulgated to employees in writing provides otherwise.  In the case of any Employee on an approved leave of absence or a reduction in hours worked (for illustrative purposes only, a change in schedule from that of full-time to part-time), the Committee may make such provisions respecting suspension or modification of vesting of the Award while on leave from the employ of the Company or a Parent, Subsidiary, or Affiliate or during such change in working hours as it may deem appropriate, except that in no event may an Award be exercised after the expiration of the term set forth in the applicable Award Agreement.  In the event of military or other protected leave, if required by applicable laws, vesting will continue for the longest period that vesting continues under any other statutory or Company approved leave of absence and, upon a Participant’s returning from military leave, he or she will be given vesting credit with respect to Awards to the same extent as would have applied had the Participant continued to provide Service to the Company throughout the leave on the same terms as he or she was providing Service immediately prior to such leave.  An employee will have terminated employment as of the date he or she ceases to provide Service (regardless of whether the termination is in breach of local employment laws or is later found to be invalid) and employment will not be extended by any notice period or garden leave mandated by local law, provided, however, that a change in status from an employee to a consultant or advisor will not terminate the service provider’s Service, unless determined by the Committee, in its discretion.  The Committee will have sole discretion to determine whether a Participant has ceased to provide Service and the effective date on which the Participant ceased to provide Service.
28.41.“Shares” means shares of the Company’s Class A common stock and the common stock of any successor entity.
19
        

28.42.“Stock Appreciation Right” means an Award defined in Section 8 and granted under the Plan.  
28.43.“Stock Bonus” means an Award defined in Section 7 and granted under the Plan. 
28.44.“Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.
28.45.“Treasury Regulations” means regulations promulgated by the United States Treasury Department.
28.46. “Unvested Shares” means Shares that have not yet vested or are subject to a right of repurchase in favor of the Company (or any successor thereto).
20
        

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN
NOTICE OF STOCK OPTION GRANT
Unless otherwise defined herein, the terms defined in the Smartsheet Inc. (the “Company”) 2018 Equity Incentive Plan (the “Plan”) will have the same meanings in this Notice of Stock Option Grant and the electronic representation of this Notice of Stock Option Grant established and maintained by the Company or a third party designated by the Company (this “Notice”).
Name:    
Address:    
You (the “Participant”) have been granted an option to purchase shares of Common Stock of the Company (the “Option”) under the Plan subject to the terms and conditions of the Plan, this Notice, and the Stock Option Award Agreement (the “Option Agreement”), including any applicable country-specific provisions in the appendix attached hereto (the “Appendix”), which constitutes part of the Option Agreement.
Grant Number:    
Date of Grant:    
Vesting Commencement Date:    
Exercise Price per Share:    
Total Number of Shares:    
									
	Type of Option:		____ Non-Qualified Stock Option
			
			____ Incentive Stock Option
			
	Expiration Date:		________ __, 20__; the Option expires earlier if Participant’s Service terminates earlier, as described in the Option Agreement.
			
	Vesting Schedule:		Subject to the limitations set forth in this Notice, the Plan, and the Agreement, the Option will vest in accordance with the following schedule: [insert applicable vesting schedule]

			

By accepting (whether in writing, electronically, or otherwise) the Option, Participant acknowledges and agrees to the following:
1)Participant understands that Participant’s Service with the Company or a Parent, Subsidiary, or Affiliate is for an unspecified duration, can be terminated at any time (i.e., is “at-will”) except where otherwise prohibited by applicable law, and that nothing in this Notice, the Option Agreement, or the Plan changes the nature of that relationship.  Participant acknowledges that the vesting of the Option pursuant to this Notice is subject to Participant’s continuing Service as an Employee, Director, or Consultant.  Participant agrees and acknowledges that the Vesting Schedule may change prospectively in the event that Participant’s Service status changes between full- and part-time and/or in the event the Participant is on a leave of absence, in accordance with Company policies relating to work schedules and vesting of Awards or as determined by the Committee.  Furthermore, the period during which Participant may exercise the Option after termination of Service, if any, will commence on the Termination Date (as defined in the Option Agreement).  
2)This grant is made under and governed by the Plan, the Agreement, and this Notice, and this Notice is subject to the terms and conditions of the Agreement and the Plan, both of which are incorporated herein by reference.  Participant has read the Notice, the Option Agreement and, the Plan.  
3)Participant has read the Company’s Insider Trading Policy, and agrees to comply with such policy, as it may be amended from time to time, whenever Participant acquires or disposes of the Company’s securities.  
4)By accepting the Option, Participant consents to electronic delivery and participation as set forth in the Option Agreement.
        
1

						
	PARTICIPANT	SMARTSHEET INC.
	Signature:        
	By:
	Print Name:        
	Its:

    2    

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN
STOCK OPTION AWARD AGREEMENT
Unless otherwise defined in this Stock Option Award Agreement (this “Option Agreement”), any capitalized terms used herein will have the meaning ascribed to them in the Smartsheet Inc. 2018 Equity Incentive Plan (the “Plan”).
Participant has been granted an option to purchase Shares (the “Option”) of Smartsheet Inc. (the “Company”), subject to the terms, restrictions, and conditions of the Plan, the Notice of Stock Option Grant (the “Notice”), and this Option Agreement, including any applicable country-specific provisions in the appendix attached hereto (the “Appendix”), which constitutes part of this Option Agreement.  In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of the Notice or this Option Agreement, the terms and conditions of the Plan shall prevail.  
1.Vesting Rights.  Subject to the applicable provisions of the Plan and this Option Agreement, the Option may be exercised, in whole or in part, in accordance with the Vesting Schedule set forth in the Notice.  Participant acknowledges and agrees that the Vesting Schedule may change prospectively in the event Participant’s Service status changes between full and part-time and/or in the event Participant is on a leave of absence, in accordance with Company policies relating to work schedules and vesting of Awards or as determined by the Committee.  Participant acknowledges that the vesting of the Option pursuant to this Notice and Agreement is subject to Participant’s continuing Service as an Employee, Director, or Consultant.
2.Grant of Option.  Participant has been granted an Option for the number of Shares set forth in the Notice at the exercise price per Share in U.S. Dollars set forth in the Notice (the “Exercise Price”).  If designated in the Notice as an Incentive Stock Option (“ISO”), the Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code.  However, if the Option is intended to be an ISO, to the extent that it exceeds the U.S. $100,000 rule of Code Section 422(d) it shall be treated as a Nonqualified Stock Option (“NSO”).
3.Termination Period.
(a)    General Rule.  If Participant’s Service terminates for any reason except death or Disability, and other than for Cause, then the Option will expire at the close of business at Company headquarters on the date three (3) months after Participant’s Termination Date (as defined below) (or such shorter time period not less than thirty (30) days or longer time period as may be determined by the Committee, with any exercise beyond three (3) months after the date Participant’s Service terminates deemed to be the exercise of an NSO).  If Participant’s Service is terminated for Cause, the Option will expire upon the date of such termination.  The Company determines when Participant’s Service terminates for all purposes under this Option Agreement.
(b)    Death; Disability.  If Participant dies before Participant’s Service terminates (or Participant dies within three (3) months of Participant’s termination of Service other than for Cause), then the Option will expire at the close of business at Company headquarters on the date twelve (12) months after the date of death (or such shorter time period not less than six (6) months or longer time period as may be determined by the Committee, subject to the expiration details in Section 7).  If Participant’s Service terminates because of Participant’s Disability, then the Option will expire at the close of business at Company headquarters on the date twelve (12) months after Participant’s Termination Date (or such shorter time period not less than six (6) months or longer time period as may be determined by the Committee, subject to the expiration details in Section 7).
(c)    No Notification of Exercise Periods.  Participant is responsible for keeping track of these exercise periods following Participant’s termination of Service for any reason.  The Company will not provide further notice of such periods.  In no event shall the Option be exercised later than the Expiration Date set forth in the Notice.
(d)    Termination.  For purposes of the Option, Participant’s Service will be considered terminated (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), as of the date Participant is no longer actively providing Services to the Company, its Parent or one of its Subsidiaries or Affiliates regardless of any notice period (i.e., 
    1    

Participant’s period of Service would not include any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any) (the “Termination Date”).  Unless otherwise provided in the Option Agreement or determined by the Company, Participant’s right to vest in the Option under the Plan, if any, will terminate as of the Termination Date and Participant’s right to exercise the Option after termination of Service, if any, will be measured from the Termination Date.
In case of any dispute as to whether and when a termination of Service has occurred, the Committee will have sole discretion to determine whether such termination of Service has occurred and the effective date of such termination (including whether Participant may still be considered to be actively providing services while on a leave of absence). 
If Participant does not exercise the Option within the termination period set forth in the Notice or the termination periods set forth above, the Option shall terminate in its entirety.  In no event, may any Option be exercised after the Expiration Date of the Option as set forth in the Notice.
4.Exercise of Option.
(a)    Right to Exercise.  The Option is exercisable during its term in accordance with the Vesting Schedule set forth in the Notice and the applicable provisions of the Plan and this Option Agreement.  In the event of Participant’s death, Disability, termination for Cause, or other cessation of Service, the exercisability of the Option is governed by the applicable provisions of the Plan, the Notice, and this Option Agreement.  The Option may not be exercised for a fraction of a Share.
(b)    Method of Exercise.  The Option is exercisable by delivery of an exercise notice in a form specified by the Company (the “Exercise Notice”), which will state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan.  The Exercise Notice will be delivered in person, by mail, via electronic mail or facsimile or by other authorized method to the Secretary of the Company or other person designated by the Company.  The Exercise Notice will be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares together with any applicable Tax-Related Items (as defined in Section 8 below).  The Option will be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by such aggregate Exercise Price and payment of any applicable Tax-Related Items.  No Shares will be issued pursuant to the exercise of the Option unless such issuance and exercise complies with all relevant provisions of law and the requirements of any stock exchange or quotation service upon which the Shares are then listed.  Assuming such compliance, for United States income tax purposes the Exercised Shares will be considered transferred to Participant on the date the Option is exercised with respect to such Exercised Shares.
(c)    Exercise by Another.  If another person wants to exercise the Option after it has been transferred to him or her in compliance with this Option Agreement, that person must prove to the Company’s satisfaction that he or she is entitled to exercise the Option.  That person must also complete the proper Exercise Notice form (as described above) and pay the Exercise Price (as described below) and any applicable Tax-Related Items (as described below).
5.Method of Payment.  Payment of the aggregate Exercise Price will be by any of the following, or a combination thereof, at the election of Participant:
(a)    Participant’s personal check (or readily available funds), wire transfer, or a cashier’s check;
(b)    certificates for shares of Company stock that Participant owns, along with any forms needed to effect a transfer of those shares to the Company; the value of the shares, determined as of the effective date of the Option exercise, will be applied to the Exercise Price.  Instead of surrendering shares of Company stock, Participant may attest to the ownership of those shares on a form provided by the Company and have the same number of shares subtracted from the Option shares issued to Participant.  However, Participant may not surrender, or attest to the ownership of, shares of Company stock in payment of the Exercise Price of Participant’s Option 
    2    

if Participant’s action would cause the Company to recognize compensation expense (or additional compensation expense) with respect to this Option for financial reporting purposes;
(c)    cashless exercise through irrevocable directions to a securities broker approved by the Company to sell all or part of the Shares covered by the Option and to deliver to the Company from the sale proceeds an amount sufficient to pay the Exercise Price and any applicable Tax-Related Items.  The balance of the sale proceeds, if any, will be delivered to Participant.  The directions must be given by signing a special notice of exercise form provided by the Company; or
(d)    other method authorized by the Company;
provided, however, that the Company may restrict the available methods of payment due to facilitate compliance with applicable law or administration of the Plan.  In particular, if Participant is located outside the United States, Participant should review the applicable provisions of the Appendix for any such restrictions that may currently apply. 
6.Non-Transferability of Option.  The Option may not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of other than by will or by the laws of descent or distribution or court order and may be exercised during the lifetime of Participant only by Participant or unless otherwise permitted by the Committee on a case-by-case basis.  The terms of the Plan and this Option Agreement will be binding upon the executors, administrators, heirs, successors, and assigns of Participant.
7.Term of Option.  The Option will in any event expire on the expiration date set forth in the Notice, which date is ten (10) years after the Date of Grant (five (5) years after the Date of Grant if this option is designated as an ISO in the Notice of Stock Option Grant and Section 5.3 of the Plan applies).
8.Taxes.
(a)    Responsibility for Taxes.  Participant acknowledges that, regardless of any action taken by the Company or a Parent, Subsidiary, or Affiliate employing or retaining Participant (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account, or other tax related items related to Participant’s participation in the Plan and legally applicable to Participant (“Tax-Related Items”) is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer, if any.  Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Option, including, but not limited to, the grant, vesting, or exercise of this Option; the subsequent sale of Shares acquired pursuant to such exercise; and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of this Option to reduce or eliminate Participant’s liability for Tax-Related Items or achieve any particular tax result.  Further, if Participant is subject to Tax-Related Items in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.  PARTICIPANT SHOULD CONSULT A TAX ADVISER APPROPRIATELY QUALIFIED IN THE COUNTRY OR COUNTRIES IN WHICH PARTICIPANT RESIDES OR IS SUBJECT TO TAXATION.
(b)    Withholding. Prior to any relevant taxable or tax withholding event, as applicable, Participant agrees to make arrangements satisfactory to the Company and/or the Employer to fulfill all Tax-Related Items.  In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy any withholding obligations for Tax-Related Items by one or a combination of the following:
(i)    withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or
(ii)    withholding from proceeds of the sale of Shares acquired at exercise of this Option either through a voluntary sale or through a mandatory sale arranged by the 
    3    

Company (on Participant’s behalf pursuant to this authorization and without further consent); 
(iii)    withholding Shares to be issued upon exercise of the Option, provided the Company only withholds the amount of Shares necessary to satisfy no more than the maximum statutory withholding amounts;
(iv)    Participant’s payment of a cash amount (including by check representing readily available funds or a wire transfer); or
(v)    any other arrangement approved by the Committee and permitted under applicable law;
all under such rules as may be established by the Committee and in compliance with the Company’s Insider Trading Policy and 10b5-1 Trading Plan Policy, if applicable; provided however, that if Participant is a Section 16 officer of the Company under the Exchange Act, then the Committee (as constituted in accordance with Rule 16b-3 under the Exchange Act) shall establish the method of withholding from alternatives (i)-(v) above, and the Committee shall establish the method prior to the Tax-Related Items withholding event.  
Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including up to the maximum permissible statutory rate for Participant’s tax jurisdiction(s) in which case Participant will have no entitlement to the equivalent amount in Shares and will receive a refund of any over-withheld amount in cash in accordance with applicable law.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Exercised Shares; notwithstanding that a number of the Shares are held back solely for the purpose of satisfying the withholding obligation for Tax-Related Items.
Finally, Participant agrees to pay to the Company and/or the Employer any amount of Tax-Related Items that the Company and/or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described.  The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items.
(c)    Notice of Disqualifying Disposition of ISO Shares.  If Participant is subject to Tax-Related Items in the United States and sells or otherwise disposes of any of the Shares acquired pursuant to an ISO on or before the later of (i) two (2) years after the grant date, or (ii) one (1) year after the exercise date, Participant will immediately notify the Company in writing of such disposition.  Participant agrees that he or she may be subject to income tax withholding by the Company on the compensation income recognized from such early disposition of ISO Shares by payment in cash or out any wages or other cash compensation paid to Participant by the Company and/or the Employer.
9.Nature of Grant.  By accepting the Option, Participant acknowledges, understands and agrees that:
(a)    the Plan is established voluntarily by the Company, it is discretionary in nature, and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(b)    the grant of the Option is exceptional, voluntary, and occasional, and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted in the past;
(c)    all decisions with respect to future options or other grants, if any, will be at the sole discretion of the Company;
(d)    Participant is voluntarily participating in the Plan;
(e)    the Option and Participant’s participation in the Plan will not create a right to employment or be interpreted as forming or amending an employment or service contract with the 
    4    

Company or the Employer, and shall not interfere with the ability of the Company or the Employer, as applicable, to terminate Participant’s employment or service relationship (if any);
(f)    the Option and the Shares subject to the Option, and the income and value of same, are not intended to replace any pension rights or compensation;
(g)    the Option and the Shares subject to the Option, and the income and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement, or welfare benefits or similar payments;
(h)    unless otherwise agreed with the Company, the Option, and the Shares subject to the Option, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Parent, Subsidiary, or Affiliate; 
(i)    the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty; if the underlying Shares do not increase in value, the Option will have no value; if Participant exercises the Option and acquires Shares, the value of such Shares may increase or decrease, even below the Exercise Price;
(j)    no claim or entitlement to compensation or damages will arise from forfeiture of the Option resulting from Participant’s termination of Service (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the Option to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Employer, the Company, and any Parent, Subsidiary, or Affiliate; waives his or her ability, if any, to bring any such claim; and releases the Employer, the Company, and any Parent, Subsidiary, or Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant will be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim;
(k)    unless otherwise provided in the Plan or by the Company in its discretion, the Option and the benefits evidenced by this Option Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares; and
(l)    neither the Employer, the Company, or any Parent, Subsidiary or Affiliate will be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the exercise of the Option or the subsequent sale of any Shares acquired upon exercise.
10.No Advice Regarding Grant.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan or Participant’s acquisition or sale of the underlying Shares.  Participant acknowledges, understands, and agrees that he or she should consult with his or her own personal tax, legal, and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.
11.Data Privacy.  Participant understands that the Employer and/or the Company need to collect and use certain personal information about the Participant (known as “personal data”) in order to administer and manage Participant's participation in the Plan.  For the purposes of data protection law, Participant's Employer and/or the Company will be the relevant data controllers.  This personal data may include, but may not be limited to, Participant’s name, home address and telephone number, email address, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of the Options or any other entitlement to Shares awarded, canceled, vested, unvested, or outstanding in Participant’s favor, for the purpose of implementing, administering, and managing the Plan (“Data”).  The Data will be processed for the 
    5    

purposes of managing Participant's participation in the Plan, for example, to maintain a record of outstanding settled/vested awards, to provide shares on vesting/settlement of awards, to enable relevant information to be supplied to taxation authorities, to enable relevant tax deductions to be made in relation to share awards, and to contact Participant in relation to events which affect Participant's participation in the Plan ("Share Plan Purposes"). The Data processed for Share Plan Purposes will be gathered: (i) from Participant directly, and/or (ii) by the Company and/or the Employer from Participant’s human resources or personnel files. Participant understands that the Data may also be held by the Employer, the Company, and its Parent, Subsidiaries, or Affiliates for other purposes associated with Participant's employment (which are or will be described in separate privacy notices or policies).  Processing the Data for Share Plan Purposes is, in most respects, necessary in order to perform this Option Agreement.  In certain cases, processing will instead be based on the legitimate interests of one or more of the Employer, the Company, and its Parent,  Subsidiaries, or Affiliates in processing the Data for the Share Plan Purposes, in order to deliver a benefit to incentivize and reward employees.  Finally, the Employer, the Company, and its Parent, Subsidiaries, or Affiliates may be required to carry out certain processing activities in order to comply with legal obligations to which they are subject. Participant understands that Data may be transferred between the Employer, the Company, and its Parent, Subsidiaries, or Affiliates, and to third parties assisting in the implementation, administration and management of the Plan (such as brokers and share plan administrators). These recipients may be located in Participant’s country or elsewhere, and the recipient’s country may have different or less stringent data privacy laws and protections than Participant’s country.  Where required by law (for example, when Data is transferred outside of the European Economic Area), the Employer, the Company, and its Parent, Subsidiaries, or Affiliates will put in place arrangements (for example, data transfer agreements) to ensure the adequate protection of the Data; non-proprietary or confidential details of such safeguards will be made available to Participant upon Participant’ written request to the Company.  Participant understands that Data will be held by the Employer, the Company, or its Parent, Subsidiaries, or Affiliates for the period specified in its records retention policy. Participant understands that he or she has certain rights in respect of the Data, including to access the data, to request erasure of the Data (where no legal basis to continue processing it exists) or to limit or object to processing, to request corrections to inaccurate Data, and to data portability.  To exercise any of these rights, or where Participant has any queries about the processing of their Data, he or she should contact: privacy@smartsheet.com. The data protection contact for the Company and its Parent, Subsidiaries, and Affiliates can be contacted directly: jolene.marshall@smartsheet.com. Participant further understand that he or she has the right to lodge a complaint with a supervisory authority in connection with the violation of the foregoing rights by the Employer, the Company, and its Parent, Subsidiaries, or Affiliates.
12.Language.  If Participant has received this Option Agreement, or any other document related to the Option and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
13.Appendix.  The Option will be subject to any special terms and conditions set forth in any appendix to this Option Agreement for Participant’s country.  Moreover, if Participant relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Option Agreement.
14.Imposition of Other Requirements.  The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Option, and on any Shares purchased upon exercise of the Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
15.Acknowledgement.  The Company and Participant agree that the Option is granted under and governed by the Notice, this Option Agreement and the Plan (incorporated herein by reference).  Participant: (a) acknowledges receipt of a copy of the Plan including the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the Option subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.
16.Entire Agreement; Enforcement of Rights.  This Option Agreement, the Plan, and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them.  Any prior agreements, commitments, or negotiations concerning the purchase of the Shares hereunder are superseded.  No adverse modification of, or adverse amendment to, this Option Agreement, nor any waiver of any rights under this Option 
    6    

Agreement, will be effective unless in writing and signed by the parties to this Option Agreement (which writing and signing may be electronic).  The failure by either party to enforce any rights under this Option Agreement will not be construed as a waiver of any rights of such party.
17.Compliance with Laws and Regulations.  The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state, federal, and foreign laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Shares may be listed or quoted at the time of such issuance or transfer.  Participant understands that the Company is under no obligation to register or qualify the Common Stock with any state, federal, or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares.  Further, Participant agrees that the Company shall have unilateral authority to amend the Plan and this Option Agreement without Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares.  Finally, the Shares issued pursuant to this Option Agreement shall be endorsed with appropriate legends, if any, determined by the Company.
18.Severability.  If one or more provisions of this Option Agreement are held to be unenforceable under applicable law, then such provision will be enforced to the maximum extent possible given the intent of the parties hereto.  If such clause or provision cannot be so enforced, then (a) such provision will be excluded from this Option Agreement, (b) the balance of this Option Agreement will be interpreted as if such provision were so excluded, and (c) the balance of this Option Agreement will be enforceable in accordance with its terms.
19.Governing Law and Venue.  This Option Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto will be governed, construed and interpreted in accordance with the laws of the State of Washington, without giving effect to such state’s conflict of laws rules.
Any and all disputes relating to, concerning or arising from this Option Agreement, or relating to, concerning or arising from the relationship between the parties evidenced by the Plan or this Option Agreement, will be brought and heard exclusively in the United States District Court for the District of Western Washington or the Superior Court of King County, Washington.  Each of the parties hereby represents and agrees that such party is subject to the personal jurisdiction of said courts; hereby irrevocably consents to the jurisdiction of such courts in any legal or equitable proceedings related to, concerning, or arising from such dispute, and waives, to the fullest extent permitted by law, any objection which such party may now or hereafter have that the laying of the venue of any legal or equitable proceedings related to, concerning, or arising from such dispute which is brought in such courts is improper or that such proceedings have been brought in an inconvenient forum. 
20.No Rights as Employee, Director or Consultant.  Nothing in this Option Agreement will affect in any manner whatsoever any right or power of the Employer or the Company to terminate Participant’s Service, for any reason, with or without Cause.
21.Consent to Electronic Delivery of All Plan Documents and Disclosures.  By Participant’s acceptance of the Notice (whether in writing or electronically), Participant and the Company agree that the Option is granted under and governed by the terms and conditions of the Plan, the Notice, and this Option Agreement.  Participant has reviewed the Plan, the Notice, and this Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Notice and Agreement, and fully understands all provisions of the Plan, the Notice, and this Option Agreement.  Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice, and this Option Agreement.  Participant further agrees to notify the Company upon any change in Participant’s residence address.  By acceptance of the Option, Participant agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company and consents to the electronic delivery of the Notice, this Option Agreement, the Plan, account statements, Plan prospectuses required by the SEC, U.S. financial reports of the Company, and all other documents that the Company is required to deliver to its security holders (including, without limitation, annual reports and proxy statements), or other communications or information related to the Option and current or future participation in the Plan.  Electronic delivery may include the delivery of a link to the Company intranet or the internet site of a third party involved in administering the Plan, the delivery of the document via e-mail, or such other delivery determined at the Company’s discretion.  Participant acknowledges that Participant may receive from the Company a paper copy of any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to 
    7    

Stock Administration.  Participant further acknowledges that Participant will be provided with a paper copy of any documents delivered electronically if electronic delivery fails; similarly, Participant understands that Participant must provide on request to the Company or any designated third party a paper copy of any documents delivered electronically if electronic delivery fails.  Also, Participant understands that Participant’s consent may be revoked or changed, including any change in the electronic mail address to which documents are delivered (if Participant has provided an electronic mail address), at any time by notifying the Company of such revised or revoked consent by telephone, postal service, or electronic mail to Stock Administration.
22.Insider Trading Restrictions/Market Abuse Laws.  Participant acknowledges that, depending on Participant’s country, Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect Participant’s ability to acquire or sell the Shares or rights to Shares under the Plan during such times as Participant is considered to have “inside information” regarding the Company (as defined by the laws in Participant’s country).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Participant acknowledges that it is Participant’s responsibility to comply with any applicable restrictions and understands that Participant should consult his or her personal legal advisor on such matters.  In addition, Participant acknowledges that he or she has read the Company’s Insider Trading Policy, and agrees to comply with such policy, as it may be amended from time to time, whenever Participant acquires or disposes of the Company’s securities.  
23.Foreign Asset/Account, Exchange Control and Tax Reporting. Participant may be subject to foreign asset/account, exchange control, and/or tax reporting requirements as a result of the acquisition, holding, and/or transfer of Shares or cash resulting from his or her participation in the Plan.  Participant may be required to report such accounts, assets, the balances therein, the value thereof, and/or the transactions related thereto to the applicable authorities in Participant’s country and/or repatriate funds received in connection with the Plan within certain time limits or according to specified procedures.  Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control, and tax reporting requirements and should consult his or her personal legal and tax advisors on such matters.
24.Award Subject to Company Clawback or Recoupment.  The Option shall be subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law during the term of Participant’s employment or other Service that is applicable to Participant.  In addition to any other remedies available under such policy, applicable law may require the cancellation of Participant’s Option (whether vested or unvested) and the recoupment of any gains realized with respect to Participant’s Option.
BY ACCEPTING THIS OPTION, PARTICIPANT AGREES TO ALL OF THE TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE PLAN.
    8    

APPENDIX
SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN
STOCK OPTION AWARD AGREEMENT
COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.
Terms and Conditions
This Appendix includes additional terms and conditions that govern the Option granted to Participant under the Plan if Participant resides and/or works in one of the countries below.  This Appendix forms part of the Option Agreement.  Any capitalized term used in this Appendix without definition will have the meaning ascribed to it in the Notice, the Option Agreement, or the Plan, as applicable.
If Participant is a citizen or resident of a country, or is considered resident of a country, other than the one in which Participant is currently working, or Participant transfers employment and/or residency between countries after the Date of Grant, the Company will, in its sole discretion, determine to what extent the additional terms and conditions included herein will apply to Participant under these circumstances.
Notifications
This Appendix also includes information relating to exchange control, securities laws, foreign asset/account reporting, and other issues of which Participant should be aware with respect to Participant’s participation in the Plan.  The information is based on the securities, exchange control, foreign asset/account reporting, and other laws in effect in the respective countries as of March 2018.  Such laws are complex and change frequently.  As a result, Participant should not rely on the information herein as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date at the time that Participant exercises the Option, sells Shares acquired under the Plan, or takes any other action in connection with the Plan.
In addition, the information is general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of any particular result.  Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to Participant’s situation.

Finally, if Participant is a citizen or resident of a country, or is considered resident of a country, other than the one in which Participant is currently working and/or residing, or Participant transfers employment and/or residency after the Date of Grant, the information contained herein may not apply to Participant in the same manner.
 
    9    

APPENDIX
SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN
STOCK OPTION AWARD AGREEMENT 

COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.
UNITED KINGDOM 

Securities Disclaimer 

The grant of the Options is exempt from the requirement to publish a prospectus under the EU Prospectus Directive as implemented in the UK.

The Option Agreement is not an approved prospectus for the purposes of section 85(1) of the Financial services and Markets Act 2000 (“FSMA”) and no offer of transferable securities to the public (for the purposes of section 102B of FSMA) is being made in connection with the Plan.  The Plan and the Options are exclusively available in the UK to bona fide employees and former employees of the Company and any UK Employer.

Labor / Employment

The Plan shall not form part of the contract of employment of any UK Participant.  The rights and obligations of any UK Participant under the terms of his office or employment with the Company or the UK Employer shall not be affected by his participation in the Plan or any right which he may have to participate in it.

Section 431 Election 

UK Participants agree that, if so requested by the Company, they shall, on vesting of the Options or on such earlier date as may be specified by the Company, enter into an irrevocable joint election with either the UK Employer or the Company, as applicable, pursuant to section 431 of Income Tax (Earnings & Pensions) Act 2003 (“ITEPA”) in a form specified by the Company that for the relevant tax purposes the market value of the Shares acquired (or to be acquired) by the UK Participant on exercise of the Options is to be calculated as if the Shares were not restricted securities (as defined in section 423 of ITEPA) and section 425 to 430 of ITEPA are not to apply to such Shares.

    10    

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN 
NOTICE OF RESTRICTED STOCK UNIT AWARD

Unless otherwise defined herein, the terms defined in the Smartsheet Inc. (the “Company”) 2018 Equity Incentive Plan (the “Plan”) will have the same meanings in this Notice of Restricted Stock Unit Award and the electronic representation of this Notice of Restricted Stock Unit Award established and maintained by the Company or a third party designated by the Company (this “Notice”).
Name:

Address:
You (the “Participant”) have been granted an award of Restricted Stock Units (“RSUs”) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Restricted Stock Unit Award Agreement (the “Agreement”), including any applicable country-specific provisions in the appendix attached hereto (the “Appendix”), which constitutes part of the Agreement.
Grant Number:

Number of RSUs:
Date of Grant:
Vesting Commencement Date:
Expiration Date:    The earlier to occur of: (a) the date on which settlement of all RSUs granted hereunder occurs, and (b) the tenth anniversary of the Date of Grant. This RSU expires earlier if Participant’s Service terminates earlier, as described in the Agreement.
Vesting Schedule:    Subject to the limitations set forth in this Notice, the Plan, and the Agreement, the RSUs will vest in accordance with the following schedule: [insert applicable vesting schedule]
By accepting (whether in writing, electronically or otherwise) the RSUs, Participant acknowledges and agrees to the following:

1)Participant understands that Participant’s Service with the Company or a Parent, Subsidiary, or Affiliate is for an unspecified duration, can be terminated at any time (i.e., is “at-will”), except where otherwise prohibited by applicable law, and that nothing in this Notice, the Agreement, or the Plan changes the nature of that relationship. Participant acknowledges that the vesting of the RSUs pursuant to this Notice is subject to Participant’s continuing Service as an Employee, Director or Consultant. Participant agrees and acknowledges that the Vesting Schedule may change prospectively in the event that Participant’s Service status changes between full- and part-time and/or in the event the Participant is on a leave of absence, in accordance with Company policies relating to work schedules and vesting of Awards or as determined by the Committee. 
2)This grant is made under and governed by the Plan, the Agreement, and this Notice, and this Notice is subject to the terms and conditions of the Agreement and the Plan, both of which are incorporated herein by reference. Participant has read the Notice, the Agreement, and the Plan.
3)Participant has read the Company’s Insider Trading Policy, and agrees to comply with such policy, as it may be amended from time to time, whenever Participant acquires or disposes of the Company’s securities.
4)By accepting the RSUs, Participant consents to electronic delivery and participation as set forth in the Agreement.
1

5)If you do not wish to receive this Restricted Stock Unit Award and/or you do not consent and agree to the terms and conditions on which this Award is offered, as set forth in the Grant Notice, the Plan and this Agreement, then you must reject the Restricted Stock Unit Award by notifying the Company no later than 30 days prior to the earliest vesting date identified in the Vesting Schedule section of this Notice, in which case the Award will be cancelled. Your failure to notify the Company of your rejection of the Restricted Stock Unit Award within this specified period will constitute your acceptance of the Award and your agreement with all terms and conditions of the Award, as set forth in the Grant Notice, the Plan and this Agreement

						
	PARTICIPANT
	SMARTSHEET INC.

	Signature:
	By:

	Print Name:
	Its:

2

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT

Unless otherwise defined in this Restricted Stock Unit Award Agreement (this “Agreement”), any capitalized terms used herein will have the same meaning ascribed to them in the Smartsheet Inc. 2018 Equity Incentive Plan (the “Plan”).

Participant has been granted Restricted Stock Units (“RSUs”) subject to the terms, restrictions, and conditions of the Plan, the Notice of Restricted Stock Unit Award (the “Notice”), and this Agreement, including any applicable country-specific provisions in the appendix attached hereto (the “Appendix”), which constitutes part of this Agreement. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of the Notice or this Agreement, the terms and conditions of the Plan shall prevail.

1.Settlement. Settlement of RSUs will be made within thirty (30) days following the applicable date of vesting under the Vesting Schedule set forth in the Notice. Settlement of RSUs will be in Shares. No fractional RSUs or rights for fractional Shares shall be created pursuant to this Agreement.

2.No Stockholder Rights. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant will have no ownership of the Shares allocated to the RSUs and will have no rights to dividends or to vote such Shares.

3.Dividend Equivalents. Dividends, if any (whether in cash or Shares), will not be credited to Participant.

4.Non-Transferability of RSUs. The RSUs and any interest therein will not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of in any manner other than by will or by the laws of descent or distribution or court order or unless otherwise permitted by the Committee on a case-by- case basis.

5.Termination.  If Participant’s Service terminates for any reason, all unvested RSUs will be forfeited to the Company forthwith, and all rights of Participant to such RSUs will immediately terminate without payment of any consideration to Participant. Participant’s Service will be considered terminated (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any) as of the date Participant is no longer actively providing services regardless of any notice period (i.e., Participant’s period of Service would not include a period of “garden leave” or similar period mandated under employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any). Participant acknowledges and agrees that the Vesting Schedule may change prospectively in the event Participant’s Service status changes between full- and part- time and/or in the event Participant is on a leave of absence, in accordance with Company policies relating to work schedules and vesting of Awards or as determined by the Committee. Participant acknowledges that the vesting of the RSUs pursuant to this Notice and Agreement is subject to Participant’s continued Service. In case of any dispute as to whether and when a termination of Service has occurred, the Committee will have sole discretion to determine whether such termination of Service has occurred and the effective date of such termination (including whether Participant may still be considered to be actively providing services while on a leave of absence).

1

6. Taxes.

(a)Responsibility for Taxes. Participant acknowledges that, regardless of any action taken by the Company or a Parent, Subsidiary or Affiliate employing or retaining Participant (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to Participant’s participation in the Plan and legally applicable to Participant (“Tax-Related Items”) is and remains Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer, if any. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs and the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends, and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax-Related Items or achieve any particular tax result. Further, if Participant is subject to Tax-Related Items in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. PARTICIPANT SHOULD CONSULT A TAX ADVISER APPROPRIATELY QUALIFIED IN THE COUNTRY OR COUNTRIES IN WHICH PARTICIPANT RESIDES OR IS SUBJECT TO TAXATION.

(b)Withholding. Prior to any relevant taxable or tax withholding event, as applicable, Participant agrees to make arrangements satisfactory to the Company and/or the Employer to fulfill all Tax-Related Items. In this regard, Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy any withholding obligations for Tax-Related Items by one or a combination of the following:

(i)    withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or

(ii)    withholding from proceeds of the sale of Shares acquired upon settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf pursuant to this authorization and without further consent);

(iii)    withholding Shares to be issued upon settlement of the RSUs, provided the Company only withholds the amount of Shares necessary to satisfy no more than the maximum statutory withholding amounts;

(iv)    Participant’s payment of a cash amount (including by check representing readily available funds or a wire transfer); or

(v)    any other arrangement approved by the Committee and permitted under applicable law;

all under such rules as may be established by the Committee and in compliance with the Company’s Insider Trading Policy and 10b5-1 Trading Plan Policy, if applicable; provided however, that if Participant is a Section 16 officer of the Company under the Exchange Act, then the Committee (as constituted in accordance with Rule 16b-3 under the Exchange Act) shall establish the method of withholding from alternatives (i)-(v) above, and the Committee shall establish the method prior to the Tax-Related Items withholding event.
2

If Participant is a Section 16 officer of the Company under the Exchange Act, unless determined otherwise by the Committee in advance of a Tax-Related Items withholding event, the method of withholding for this RSU will be (iii) above.

Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates or other applicable withholding rates, including up to the maximum permissible statutory rate for Participant’s tax jurisdiction(s) in which case Participant will have no entitlement to the equivalent amount in Shares and will receive a refund of any over-withheld amount in cash in accordance with applicable law. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of satisfying the withholding obligation for Tax-Related Items.

Finally, Participant agrees to pay to the Company and/or the Employer any amount of Tax-Related Items that the Company and/or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items.

7.Nature of Grant. By accepting the RSUs, Participant acknowledges, understands and agrees that:

(a)    the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;

(b)    the grant of the RSUs is exceptional, voluntary, and occasional, and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;

(c)    all decisions with respect to future RSUs or other grants, if any, will be at the sole discretion of the Company;

(d)    Participant is voluntarily participating in the Plan;

(e)    the RSUs and Participant’s participation in the Plan will not create a right to employment or be interpreted as forming or amending an employment or service contract with the Company or the Employer and shall not interfere with the ability of the Company or the Employer, as applicable, to terminate Participant’s employment or service relationship (if any);

(f)    the RSUs and the Shares subject to the RSUs, and the income and value of same, are not intended to replace any pension rights or compensation;

(g)    the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement, or welfare benefits or similar payments;

(h)    unless otherwise agreed with the Company, the RSUs, and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Parent, Subsidiary, or Affiliate;
			
	

3

(i)    the future value of the underlying Shares is unknown, indeterminable, and cannot be predicted with certainty;

(j)    no claim or entitlement to compensation or damages will arise from forfeiture of the RSUs resulting from Participant’s termination of Service (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant’s employment agreement, if any), and in consideration of the grant of the RSUs to which Participant is otherwise not entitled, Participant irrevocably agrees never to institute any claim against the Employer, the Company, and any Parent, Subsidiary or Affiliate; waives his or her ability, if any, to bring any such claim; and releases the Employer, the Company, and any Parent, Subsidiary, or Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, Participant will be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim;

(k)    unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits evidenced by this Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Shares; and

(l)    neither the Employer, the Company, or any Parent, Subsidiary, or Affiliate will be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement.

8.No Advice Regarding Grant. The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant acknowledges, understands and agrees he or she should consult with his or her own personal tax, legal, and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

9.Data Privacy. Participant understands that the Employer and/or the Company need to collect and use certain personal information about the Participant (known as ‘personal data’) in order to administer and manage Participant’s participation in the Plan. For the purposes of data protection law, the Employer and/or the Company will be the relevant data controllers. This personal data may include, but may not be limited to, Participant’s name, home address and telephone number, email address, date of birth, social insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of the RSUs or any other entitlement to Shares awarded, canceled, vested, unvested, or outstanding in Participant’s favor, for the purpose of implementing, administering, and managing the Plan (“Data”). The Data will be processed for the purposes of managing Participant’s participation in the Plan, for example, to maintain a record of outstanding settled/vested awards, to provide shares on vesting/settlement of awards, to enable relevant information to be supplied to taxation authorities, to enable relevant tax deductions to be made in relation to share awards, and to contact Participant in relation to events which affect Participant’s participation in the Plan (“Share Plan Purposes”). The Data processed for Share Plan Purposes will be gathered: (i) from Participant directly, and/or (ii) by the Company and/or the Employer from Participant’s human resources or personnel files. Participant understands that the Data may also be held by the Employer, the Company, and its Parent, Subsidiaries, or Affiliates for other purposes associated with Participant’s employment (which are or will be described in separate privacy notices or policies). Processing the Data for Share Plan Purposes is, in most respects, necessary in order to perform this Agreement. In certain cases, processing will instead be based on the legitimate interests of one or more of the Employer, the Company, and its Parent, Subsidiaries, or Affiliates in processing the
			
	

4

Data for the Share Plan Purposes, in order to deliver a benefit to incentivize and reward employees. Finally, the Employer, the Company, and its Parent, Subsidiary, or Affiliates may be required to carry out certain processing activities in order to comply with legal obligations to which they are subject. Participant understands that Data may be transferred between the Employer, the Company, and its Parent, Subsidiaries, or Affiliates, and to third parties assisting in the implementation, administration and management of the Plan (such as brokers and share plan administrators). These recipients may be located in Participant’s country or elsewhere, and the recipient’s country may have different or less stringent data privacy laws and protections than Participant’s country. Where required by law (for example, when Data is transferred outside of the European Economic Area), the Employer, the Company, and any Parent, Subsidiaries, or Affiliates will put in place arrangements (for example, data transfer agreements) to ensure the adequate protection of the Data; non-proprietary or confidential details of such safeguards will be made available to Participant upon Participant’ written request to the Company. Participant understands that Data will be held by the Employer, the Company, or its Parent, Subsidiaries, or Affiliates for the period specified in its records retention policy. Participant understands that he or she has certain rights in respect of the Data, including to access the data, to request erasure of the Data (where no legal basis to continue processing it exists) or to limit or object to processing, to request corrections to inaccurate Data, and to data portability. To exercise any of these rights, or where Participant has any queries about the processing of their Data, he or she should contact: legal.privacy@smartsheet.com. The data protection contact for the Company and its Parent, Subsidiaries, and Affiliates can be contacted directly: legal.privacy@smartsheet.com. Participant further understands that he or she has the right to lodge a complaint with a supervisory authority in connection with the violation of the foregoing rights by the Employer, the Company, and its Parent, Subsidiaries, and Affiliates.

10.Language. If Participant has received this Agreement or any other document related to the RSU and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

11.Appendix. The RSUs will be subject to any special terms and conditions set forth in any appendix to this Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendix constitutes part of this Agreement.

12.Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

13.Acknowledgement. The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement, and the Plan (incorporated herein by reference). Participant: (a) acknowledges receipt of a copy of the Plan including the Plan prospectus, (b) represents that Participant has carefully read and is familiar with their provisions, and (c) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.

14.Entire Agreement; Enforcement of Rights. This Agreement, the Plan, and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments, or negotiations concerning the purchase of the Shares hereunder are superseded. No adverse modification of or adverse amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the parties to this Agreement (which writing and signing may be electronic). The failure by either

			
	

5

party to enforce any rights under this Agreement will not be construed as a waiver of any rights of such party.

15.Compliance with Laws and Regulations. The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state, federal, and foreign laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s Shares may be listed or quoted at the time of such issuance or transfer. Participant understands that the Company is under no obligation to register or qualify the Common Stock with any state, federal, or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares. Further, Participant agrees that the Company shall have unilateral authority to amend the Plan and this RSU Agreement without Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares. Finally, the Shares issued pursuant to this RSU Agreement shall be endorsed with appropriate legends, if any, determined by the Company.

16.Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, then such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, then (a) such provision will be excluded from this Agreement, (b) the balance of this Agreement will be interpreted as if such provision were so excluded, and (c) the balance of this Agreement will be enforceable in accordance with its terms.

17.Governing Law and Venue. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto will be governed, construed, and interpreted in accordance with the laws of the State of Washington, without giving effect to such state’s conflict of laws rules.

Any and all disputes relating to, concerning or arising from this Agreement, or relating to, concerning, or arising from the relationship between the parties evidenced by the Plan or this Agreement, will be brought and heard exclusively in the United States District Court for the District of Western Washington or the Superior Court of King County, Washington. Each of the parties hereby represents and agrees that such party is subject to the personal jurisdiction of said courts; hereby irrevocably consents to the jurisdiction of such courts in any legal or equitable proceedings related to, concerning, or arising from such dispute, and waives, to the fullest extent permitted by law, any objection which such party may now or hereafter have that the laying of the venue of any legal or equitable proceedings related to, concerning, or arising from such dispute which is brought in such courts is improper or that such proceedings have been brought in an inconvenient forum.

18.No Rights as Employee, Director or Consultant. Nothing in this Agreement will affect in any manner whatsoever any right or power of the Employer or the Company to terminate Participant’s Service, for any reason, with or without Cause.

19.Consent to Electronic Delivery of All Plan Documents and Disclosures. By Participant’s acceptance of the Notice (whether in writing or electronically), Participant and the Company agree that the RSUs are granted under and governed by the terms and conditions of the Plan, the Notice, and this Agreement. Participant has reviewed the Plan, the Notice, and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Notice and Agreement, and fully understands all provisions of the Plan, the Notice, and this Agreement. Participant hereby agrees to accept as binding, conclusive, and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice, and this Agreement. Participant further agrees to notify the Company upon any change in Participant’s residence address. By acceptance of the RSUs, Participant agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company and consents to the electronic delivery of the Notice, this Agreement, the

			
	

6

Plan, account statements, Plan prospectuses required by the SEC, U.S. financial reports of the Company, and all other documents that the Company is required to deliver to its security holders (including, without limitation, annual reports and proxy statements), or other communications or information related to the RSUs and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the internet site of a third party involved in administering the Plan, the delivery of the document via e-mail, or such other delivery determined at the Company’s discretion. Participant acknowledges that Participant may receive from the Company a paper copy of any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to Stock Administration. Participant further acknowledges that Participant will be provided with a paper copy of any documents delivered electronically if electronic delivery fails; similarly, Participant understands that Participant must provide on request to the Company or any designated third party a paper copy of any documents delivered electronically if electronic delivery fails. Also, Participant understands that Participant’s consent may be revoked or changed, including any change in the electronic mail address to which documents are delivered (if Participant has provided an electronic mail address), at any time by notifying the Company of such revised or revoked consent by telephone, postal service, or electronic mail to Stock Administration.

20.Insider Trading Restrictions/Market Abuse Laws. Participant acknowledges that, depending on Participant’s country, Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect Participant’s ability to acquire or sell the Shares or rights to Shares under the Plan during such times as Participant is considered to have “inside information” regarding the Company (as defined by the laws in Participant’s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. Participant acknowledges that it is Participant’s responsibility to comply with any applicable restrictions and understands that Participant should consult his or her personal legal advisor on such matters. In addition, Participant acknowledges that he or she read the Company’s Insider Trading Policy, and agrees to comply with such policy, as it may be amended from time to time, whenever Participant acquires or disposes of the Company’s securities.

21.Foreign Asset/Account, Exchange Control and Tax Reporting. Participant may be subject to foreign asset/account, exchange control, and/or tax reporting requirements as a result of the acquisition, holding, and/or transfer of Shares or cash resulting from his or her participation in the Plan. Participant may be required to report such accounts, assets, the balances therein, the value thereof, and/or the transactions related thereto to the applicable authorities in Participant’s country and/or repatriate funds received in connection with the Plan within certain time limits or according to specified procedures. Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control, and tax reporting requirements and should consult his or her personal legal and tax advisors on such matters.

22.Code Section 409A. For purposes of this Agreement, a termination of employment will be determined consistent with the rules relating to a “separation from service” as defined in Section 409A of the Internal Revenue Code and the regulations thereunder (“Section 409A”). Notwithstanding anything else provided herein, to the extent any payments provided under this RSU Agreement in connection with Participant’s termination of employment constitute deferred compensation subject to Section 409A, and Participant is deemed at the time of such termination of employment to be a “specified employee” under Section 409A, then such payment shall not be made or commence until the earlier of (a) the expiration of the six (6) month period measured from Participant’s separation from service to the Employer or the Company, or (b) the date of Participant’s death following such a separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Participant including, without limitation, the additional tax for which Participant would otherwise be liable under Section 409A(a)(1)(B) in the absence of such a deferral. To the extent any payment under this RSU
			
	

7

Agreement may be classified as a “short-term deferral” within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

23.Award Subject to Company Clawback or Recoupment. The RSUs shall be subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law during the term of Participant’s employment or other Service that is applicable to Participant. In addition to any other remedies available under such policy, applicable law may require the cancellation of Participant’s RSUs (whether vested or unvested) and the recoupment of any gains realized with respect to Participant’s RSUs.

BY ACCEPTING THIS AWARD OF RSUS, PARTICIPANT AGREES TO ALL OF THE TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE PLAN.
			
	

8

APPENDIX

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT

COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.

Terms and Conditions

This Appendix includes additional terms and conditions that govern the RSUs granted to Participant under the Plan if Participant resides and/or works in one of the countries below. This Appendix forms part of the Agreement. Any capitalized term used in this Appendix without definition will have the meaning ascribed to it in the Notice, the Agreement, or the Plan, as applicable.

If Participant is a citizen or resident of a country, or is considered resident of a country, other than the one in which Participant is currently working, or Participant transfers employment and/or residency between countries after the Date of Grant, the Company will, in its sole discretion, determine to what extent the additional terms and conditions included herein will apply to Participant under these circumstances.

Notifications

This Appendix also includes information relating to exchange control, securities laws, foreign asset/account reporting, and other issues of which Participant should be aware with respect to Participant’s participation in the Plan. The information is based on the securities, exchange control, foreign asset/account reporting, and other laws in effect in the respective countries as of March 2018. Such laws are complex and change frequently. As a result, Participant should not rely on the information herein as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date at the time that Participant vests in the RSUs, sells Shares acquired under the Plan, or takes any other action in connection with the Plan.

In addition, the information is general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of any particular result. Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to Participant’s situation.

Finally, if Participant is a citizen or resident of a country, or is considered resident of a country, other than the one in which Participant is currently working and/or residing, or Participant transfers employment and/or residency after the Date of Grant, the information contained herein may not apply to Participant in the same manner.
9

APPENDIX

SMARTSHEET INC.
2018 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT

COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.

AUSTRALIA
Terms and Conditions
Offer Document.  This document sets out information regarding the grant of RSUs under the Plan to Australian resident employees of the Company and certain of its Subsidiaries and Affiliates (“Australian Participants”).  This information is provided by the Company to ensure compliance of the Plan with Australian Securities and Investments Commission (“ASIC”) Class Order 14/1000 and relevant provisions of the Corporations Act 2001.
Additional Documents
In addition to the information set out in the Notice and the Agreement, including this Appendix, Australian Participants are also being provided with copies of the following documents:
(1)the Plan;
(2)the Plan Prospectus; and
(3)the RSU employee tax supplement for Australia.
(collectively, the “Additional Documents”).
The Additional Documents set out, amongst other details, the nature of the RSUs and the consequences of a change in the nature or status of Service.  Neither the Plan nor the Plan Prospectus is a prospectus for purposes of the Australian Corporations Act 2001 and has not been modified for Australia.
Australian Participants should not rely upon any oral statements made in relation to the grant of RSUs.  Australian Participants should rely only upon the statements contained in the Agreement, including this Appendix, and the Additional Documents when considering participation in the Plan.
General Information Only
The information herein is general information only.  It is not advice or information that takes into account Australian Participants’ objectives, financial situation and needs.
Australian Participants should consider obtaining their own financial product advice from a person who is licensed by ASIC to give such advice.
Acquisition Price
No acquisition price is payable by the Participant for the Company to grant him or her the number of RSUs set forth in the Notice or for him or her to acquire Shares upon vesting and settlement of the RSUs.
Risk Factors for Australian Residents
1)Price of Shares may fluctuate. Australian Participants should have regard to risk factors relevant to investment in securities generally and, in particular, to holding Shares.  Before accepting the Award, Australian Participants should satisfy themselves that they have a sufficient understanding of these matters and should consider whether shares of Common Stock are a suitable investment for them, having regard to their own investment objectives, financial circumstances and taxation position.  
10

For example, the price at which an individual Share is quoted on the New York Stock Exchange (“NYSE”) may increase or decrease due to a number of factors.  There is no guarantee that the price of a Share will increase.  Factors that may affect the price of an individual Share include, without limitation, fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks. 

More information about potential factors that could affect the Company’s business and financial results are included in the Company’s most recent Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q.  Copies of these reports are available at http://www.sec.gov/, on the Company’s “Investors” page at https://investors.smartsheet.com/home/default.aspx, and upon request to the Company.
In addition, Australian Participants should be aware that the Australian dollar (“AUD”) value of any Shares acquired under the Plan will be affected by the United States dollar / AUD exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange. 

2)Trading in Shares May Not be Liquid. There can be no guarantee that an active market in Shares will continue or that the price of such Shares will increase.  The number of potential buyers or sellers of the Common Stock on the NYSE may vary at any time.  This may increase the volatility of the market price of the Common Stock.  It may also affect the prevailing market price at which stockholders are able to sell their Shares.  This may result in stockholders receiving a market price for their Shares that is less than the price that stockholders paid.

3)Risk of Dilution. In the future, the Company may elect to issue stock (or securities convertible into stock) including in connection with fundraisings for acquisitions that the Company may decide to make.  Stockholders may be diluted as a result of such issues of stock or securities or such issues may reduce the market price of the Common Stock.
4)Dividends on Shares.  Payment of dividends (if any), and the timing and amount of any dividends the Company determinates to pay, is at the discretion of the Board.
Common Stock in a U.S. Corporation
Common stock of a U.S. corporation is analogous to ordinary shares of an Australian corporation.  Each holder of a Share is entitled to one vote.  Further, Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.
Ascertaining the Market Price of Shares
Australian Participants may ascertain the current market price of an individual Share as traded on the NYSE under the symbol “SMAR” at: https://www.nyse.com/quote/XNYS:SMAR.  The AUD equivalent of that price can be obtained at: https://www.rba.gov.au/statistics/frequency/exchange-rates.html.
This will not be a prediction of the market price of an individual Share when such Shares are issued under the Plan or of the applicable exchange rate on the vesting date
Notifications
Tax Information.  The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).
Exchange Control Information.  It is Participant’s sole responsibility to investigate and comply with any applicable exchange control laws in connection with the inflow to Australia of funds from the sale of any Shares received pursuant to the Award and any dividends (if any), including to report any inbound international fund transfers as required under applicable law.  Participant is encouraged to seek appropriate professional advice as to how the exchange control regulations apply to Participant’s specific situation. 
11

GERMANY 
Notifications
Exchange Control Information.  Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank. In case of payments in connection with securities (such as the Shares), the report must generally be made electronically by the fifth day of the month following the month in which the payment was received.  The form of report (“Allgemeine Meldeportal Statistik”) can be accessed at www.bundebank.de. In addition, Participant may be required to report the acquisition of Shares to the Bundesbank in the same manner and by the same deadline as described above if the value of the Shares acquired exceeds €12,500.
JAPAN
Notifications
Exchange Control Information. If Participant acquires Shares valued at more than ¥100,000,000 in a single transaction, Participant must file a “Securities Acquisition Report” with the Ministry of Finance through the Bank of Japan within twenty (20) days of the acquisition of such shares.  
Foreign Asset/Account Reporting Information.  If Participant holds assets (e.g., Shares acquired under the Plan, proceeds from the sale of Shares and, possibly, RSUs) outside of Japan with a value exceeding ¥50 million as of December 31st of any calendar year, Participant is required to report such assets to the Japanese tax authorities by March 15th of the following year.  Participant should consult with his or her personal tax advisor regarding the details of this reporting obligation.
UNITED KINGDOM
Terms and Conditions
Taxes.  The following provision supplements Section 6 of the Agreement:
Participant agrees to be liable for any Tax-Related Items and hereby covenants to pay any such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority).  Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on Participant’s behalf.
Notwithstanding the foregoing, if Participant is an executive officer or director of the Company (within the meaning of Section 13(k) of the Exchange Act), Participant acknowledges that he or she may not be able to indemnify the Company or the Employer for the amount of any income tax not collected from or paid by Participant, as it may be considered a loan.  In this case, the amount of any income tax not collected within ninety (90) days of the end of the U.K. tax year event giving rise to the Tax-Related Item(s) occurs may constitute a benefit to Participant on which additional income tax, National Insurance Contributions (“NICs”) and Health and Social Care levy may be payable.  Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and/or the Employer (as appropriate) the amount of any NICs and employee Health and Social Care levy due on this additional benefit, which may also be recovered from Participant at any time by any of the means referred to in Section 6(b) of the Agreement.
12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]